var title_f32_1_32784="Split-nail complication";
var content_f32_1_32784=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83966&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83966&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Split-nail complication",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 449px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32784=[""].join("\n");
var outline_f32_1_32784=null;
var title_f32_1_32785="Patient information: Atelectasis (The Basics)";
var content_f32_1_32785=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?4/59/5043\">",
"         Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?39/30/40418\">",
"         Patient information: Pneumothorax (collapsed lung) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?1/13/1236\">",
"         Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/50/28450\">",
"         Patient information: Shortness of breath (dyspnea) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Atelectasis (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/atelectasis-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H14886583\">",
"      <span class=\"h1\">",
"       What is atelectasis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Atelectasis is a condition that happens when part or all of a lung collapses. This means the lung does not blow up to its normal size with each breath. It can happen if something presses on the lung or blocks the air flow inside it. It can also happen if something gets stuck in the tubes that carry air to the lungs and inside the lungs. Doctors call these tubes &ldquo;airways.&rdquo;",
"     </p>",
"     <p>",
"      Atelectasis can cause breathing problems. A person with atelectasis might not get enough oxygen in his or her blood. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14886598\">",
"      <span class=\"h1\">",
"       What are the symptoms of atelectasis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Atelectasis does not always cause symptoms. If it does, the symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Breathing problems &ndash; A person with atelectasis might struggle to breathe. He or she might not be able to take a deep breath.",
"       </li>",
"       <li>",
"        Skin or lips that look blue &ndash; This can be a sign of not getting enough oxygen in the blood.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14886613\">",
"      <span class=\"h1\">",
"       Is there a test for atelectasis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. The doctor or nurse will do an exam and chest X-ray. This can show if part or all of a lung has collapsed. It can also show which part of the lung and how much of it collapsed.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14886628\">",
"      <span class=\"h1\">",
"       How is atelectasis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Medicines and other treatments for pneumonia or any other disease that is causing the atelectasis.",
"       </li>",
"       <li>",
"        Treatments to break up mucus in the lungs and get it out, if mucus is blocking the air flow &ndash; These can include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Medicines",
"       </li>",
"       <li>",
"        A treatment called &ldquo;chest physiotherapy&rdquo; &ndash; This can help atelectasis caused by mucus stuck in the lungs. There is more than 1 way to do this. For example, a physical therapist might thump the back to loosen mucus. Other ways involve using special devices. These include a vibrating bed, a vibrating vest, and devices a person can breathe into.",
"       </li>",
"       <li>",
"        Devices to help a person cough",
"       </li>",
"       <li>",
"        Sucking mucus out of the airway",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Other treatments. These can include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Oxygen &ndash; Given through a mask over the face or a tube into the nose",
"       </li>",
"       <li>",
"        Devices to help open the airway and lung &ndash; A person can wear a device that keeps the airway open called a &ldquo;continuous positive airway pressure&rdquo; (CPAP) machine.",
"       </li>",
"       <li>",
"        Surgery &ndash; If atelectasis is caused by something pressing on the lungs, such as a tumor or cyst, doctors can do surgery to take it out.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14886643\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/30/40418?source=see_link\">",
"       Patient information: Pneumothorax (collapsed lung) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/59/5043?source=see_link\">",
"       Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/13/1236?source=see_link\">",
"       Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/50/28450?source=see_link\">",
"       Patient information: Shortness of breath (dyspnea) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?32/1/32785?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83157 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-07C1274D5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32785=[""].join("\n");
var outline_f32_1_32785=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14886583\">",
"      What is atelectasis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14886598\">",
"      What are the symptoms of atelectasis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14886613\">",
"      Is there a test for atelectasis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14886628\">",
"      How is atelectasis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14886643\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/13/1236?source=related_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/59/5043?source=related_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/30/40418?source=related_link\">",
"      Patient information: Pneumothorax (collapsed lung) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/50/28450?source=related_link\">",
"      Patient information: Shortness of breath (dyspnea) (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_1_32786="Scrotal anatomy";
var content_f32_1_32786=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 496px\">",
"   <div class=\"ttl\">",
"    Normal testicular anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 476px; height: 467px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHTAdwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACigmkzQAtFMaRV6kUeYCm4EY9c0APoqqt5G3Qj86kScOcAiha7DacXZk1FN38gcVG1wocr3zigVyaimh1PQ06gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKQsB1oAWkJA61Wnu0jByax7zV1XODUymkXGm5G5JcInUis+71WOJT8wrlL3Wic4aufvdTkkJG41zzr22OqGGvueg2uq+e3ynqaW81MxzJED8zGsPw2h8sO/8I5qMv8AadUkcttSMcn+77/h1rldeT26jdKKb8jnfEXjB4NV1KNJTiGQRcHoQOR+YNSDxsqeBxL5v+ky3LQLzz0BP6H9a8cvr5rmS5lyc3Fw8xz7k/41i6pcXMKJLHI5jjJYpnjnGT9eBX1WZYKUME3SV5Jf8OeVkdejVzOnHEu0G/8AhvxseqHx8yahHAJTwCTz7V3/AID8RjVdbkty+Q1r5i8/7Sj+teS/AbQrbWdT1DVtZj820CNBGGHylnGD+S5/76FOvRqPw+8ZxBD5iwOZIWJ4mgbIIP4ZHsa83KI/WMPKk/j1a8/6Z6nFHs8Pj17J+6kk/J7/AJNH0HDfKLmQO3yxBmY+gFcZ4f8AFh1LWYkzw4eYj0ABb+lZGt+JUuPAeo6hp8gL3QFqozyrSHDA+4XdXN/DX59Q8QXQOUtdPaNPYtgA/oa640eShVqzW2nz/pniKq51YQj1PXrbXkfvWpbaqjd68msLp8da2rW+Zcc14Ua7Pfnhkenw3UcvQjNWK4Gy1NgRzXRWOqhgAxzXTCqmcs6LjsblFRxSrIuVNSVqYBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUhIA5qnd3QjU5OKTdhpXJ5p1RetY99qaxg4asrU9XxkKa5q7v2kY5Nc9StbY66WHvqzVv9VZicGsK6vWc9aryylqrsTmuWU2zthTURZJSc5NNtEM13GPfNMbpWn4et/Mud5HA4FYyehb0R2NmotdKZu5Fc7q0n2Hwfrl/wDxfZ3VT6M/yD/0Kt3V5fLs1iXqcCuL+Ld7/Z/gqy09f9Zfz5b/AHI+T/49trpy+l7bFU4LueXjKns8POXc848MaIl7Z6lql+G/s3TosuFbaZHIJVQfw/Uetczpkiagrwt8s38IPr6V1st+LL4cWmmRyDztTvXu5Ap5EKYQA/VlJ/4DXHeFNHu/EXjNbLTGWNmVzub7owpIz9SAPxr26meTp5k6D+BaP/P/ADOjDcLwqZG8dLSo9V6L/Pp8j1n4Y+KdE0/QYtC1FBps0Bdo7nkpLuYn5vQ849OPwqt8VNR0+/tNPSzuIbmdJCwaJw+1COQSPU4/KuAvSSTJKhSTkSIRgqw4IxXoel/Dy5isLW41i7+z+em9YLYAOoOD8zEdeegH416ssPh8JUVW9r7L/I+UdetiU1LV9X/mecITG25RhvX0rvvhe2NI8WHP/LGAfm7VmfEXwxb+GrzTvsdzNPDeQGT98QWVgRnkAccir/w3bboPij/a+yr/AOPOf6U8yrRq4CdSGzt+aHgKcoYyEZG1ZjC5q6j7TVe2XCCpG4r4dH25oRTEYxV+1vihHNYUcmDip9xAyKtSsRKCZ2+map0+auotLhZkGDXlFrdlGHNdVo+p4ZfmrppVejOOtQ6o7WiobWdZowQamrrOFqwUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABSMwUZNDEKMms29vAgPNJuw4q4t9diNSc1yeramWyFam6tqJZiAa5+eUuTmuOpVvojvo0basbcTs5PNVic9ac5qMmuds7EhDTDTiaaTUjGHrXT+GoNqKx+tcyi75FX1OK7jS4/Ltc44ArOozOo9LBcqbi/iTsOa8g+KWrDVvEk/lPutLLFpBjoSv32/76yPoBXo3iXVzpGkXV5GR9qc+Tbj/bbofw5P4V5Bp+nQahNqck7yDTNJs3mdkOC74wig+rOR+Ga+hyKnGjCeMq6Jf0/8jwcy5684YSlrJ/rschqhe1zcR56FT9DXpP7PtgIGm1WRfnlmWFWPpwW/mtefrsvLRl+8rL+le6+BLW1tPAugGwbcvlN5jY58zed2fx4+mK1zLAQ+sxxdP4Zr8bafejuw2dVVlk8trX54Oy/w3u18mrejOB+Lunf2f441JI0CRXIW6QD1YfMf++g1euPrNtr+jaTe2p3LNFllHVWHBX8CDXB/HjZJrWkTpgu9mc/TcSP5mtb4P2TnRLFm+49w8g+gOP8A2U11VrTwdKtLeP8Aw36HgQvGvOmtmcZ8VbmWTxTHayggWluq7T2LfN/IitTwRaNB4G1C8YYF3fxxL7hEY5/Nj+Vc98RtRh1jxzqt1ZESRNIsMZU5DlVCZHsSK9MvLJdK8C6Lpq4zE7FyO7clj+bGlmc3TwEKdrOVr/m/xN8thz41y7FC2H7sUSii2+6KWWvlT6wrltpqzG+5KpzH5TRay8YNJMbROXKtV6xvDG45rLmPOaasm1gc0J2YnG6PTtB1HO0E8V1aMHUMO9eU6JeFSvNeiaLdedCATzXfRqXVjzMRT5Xc06KKK6DlCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACgnA5oqteTCNCBSbsNK5Uv7vGQDwK5PVtRJJCmrOs34UEA81ylzcF2JzXJVqdDvo0uoTSlmJJqAvTC2aYWrmudiQ5jmomfmmvJ2FMXnmpuUkPzmlPSgChqAJ9PTzLpPau2mIt9NA6EiuW8PxeZdj610us/fhhHfFZSOeo7yseY/E292Xun2u7/UwPcMP9pjgfy/WsBkOm/DaIA4n168LMfWCHjH/AH2c/hVX4gXT3Hi3VWJwI3ECj0CgL/TNS+M3+zXGm6d0TTdOhUr2Eki+a5/8fH5V9Bmr+qZTToreVv8ANmfCdD67njqyWlO8vu0X42OL0SXy9ektDzET+QPB/mK9e+HOp2Vj4X1W01G+gge2u/NjSRwGIZQDtHU8r2rzbwnYg6Dq+sSD5nu4LONvqTI36Rj8609E0q+1/XxZaXEj3DlnLP8AdjUdWJ9K7coj7fLkqrsovfyRw8V8tPOKjpLV2v6tf8MS+L9Wk1rWftbbxAqCKBH6qg/xJJ/GrFt4k1K10A6XZ3scNoVZSQn70KxJKg+hyfetPxd4Ts9D0UXM1/cSaiZAgRgArnvgdRgZOc/zql4J8FXniyHUJreZLeO1TCMy5EkuMhPYY6ntkcV66qYb2ClL4I9z5rlq+0st2UPA0EM/jDSopgPLEhkwfVFLD9QK9e8VDbpmnf7UkjD/AMdrxXTJpNH1q0uZ0KtbXG2VT1XBww/LNe4+PQkf9lRRkMixswI6HOOf0rxuIG/dfRnq5Ivf9Dn4egp0vSmRGllPFfNH1JUl71UgkxIR71ak71nIcXB+tQy0aDnIqGZsAU/PFQ3RAQGhgammzbStd74avMOoJ615rZtgCur0O4KOpzW1KVmc9eHMj1JTkAilqrp0wmtlOe1Wq9JO55DVnYKKKKYgooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAGyNsUmud1i8CIea1dQnCqRnpXC65eF3IB4rCrOyOmhT5mZWo3JkcnNZrPTp3yarsa4G7npxjZEheoJHprvgVCCXbaKm5dh6ku2B0q0i4FJDEAAAKtKgA5ppCbISvFNNTPiq0h5oEdN4Qi3Tbu1al23m6woAztqHwjFstt56las6cPN1lmPIB/rWb10OWb95s8B8eR7PFetr1CXjA+43Vk+JdXOrzalqZHlm5kLKmc7V6Kv4AAfhW540lR/Getl/wDVvdSA4+vWuQ1LTrqM4iAltmbdlelfS59ga2Jw1GVJX5VqvVL/ACK4LzTC4HE14YmSi57N7b6q/S+n3HZSRHS/hh4dsjxJfXU2oMO4CgRqfx5Neo/AOwWPw/f6gyfvbm42BsdUQDH6lq8217PibxLYaXoQ8yC1torGB8EKVRcvJ9M7jnuBXunhi1j0Lwn9lsxv+xwsRxy7AEk/icn8aqtH6tl1PDfadmzw8RX+uZjVxXS7t/XoeL/FrU/7Q8Y30aH/AEazYQIB034G8/XPH4V6R8NY10fwIkLHFxOTOw93Ax+gFeFXkjyWMU0rF5ZmeR2PVmJ5Jr33S4w+j6fIhzHLbxuh9QVBrtzCmqeHp0ei/Q87DTcqsqh4x40jCeINdj9JFlH1YAn+ddtp9/LqHhbw7JO26RLRo8+yyOg/RRXCeMbgS6/r0gYEed5QI77fl/pXa6Rbva+HNBik4b7H5n4PI7j9GFY51ZYOnfe6/I7Mn/3qVtrM0I+lLL0pFOKRzkV8qfUlWTvWbn/STWk/Wson/SWqWWi8G6VDfN+7WnKeRUF+3zItIZetOEFbmmSbXFYFu2FFaVlLhxVxdiJK6PU/DU+6IKTW9XE+GLjEijPWu2ByAa9Kk7xPHrxtIKKKK1MQooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKZK+yMmn1R1OXam0Um7IaV2Ymr3OEbmuH1CXc7c1va3c4yM1yV1LljXn1ZXZ6lCFkRSNk1ExpC1RyNxWB1JEcjdasWkeBk9TVaMeZIB2FaMWAKEDJkGKczUzNIxqiRrmq8nJA9ambpUEXz3sKerj+dSwPQNHHlWjAelJoZ2i6nzyoYj8sf1pITssHI9KNNXGlyH+84H9f6VNFc1SKOGs+WnJnzn42lZ9f1Vk4P2iT8MGsqwuZ7e4MLyEHAORxkGtfxWoOv6uOv+mSj/AMeNcuJS+qRtn/lng19fiq9XD43DcrfLNWa6dNfxMMrwlDGZRjFKK56bUlLr109NPxPbfgTa/adf1a5b5mitBGM9i7f/AGFesaBIPOnt3GeM8968z/Z6dRe68hI3tHAwHsC+f5iuu8Sa3F4Xubm6lG+TkQxA8yMRwPp61y5jGVXFzprfS33Hj4VqnQjN+Z4X4gtks9SvbFPuWt1NCv8AuhiBXT+HPiANL8Itpd1DNJe22RZyKAV2n+Fuc8H68ccVxt+7vdSvM++Z2LyN6seTVbivpJ4eFaCjU1seTGtKnJuPUs6bY3Gt6vaafDlri7mAJPueSfpya9o8XwR2msRWsA2xQW8cSD0UDArg/g2gPjyGU4/dRNj6nC/1Nd/47P8AxU0n/XNP5V83xDVbqRp9EvzPoMigtZdWY/amOeDT+1Rv0r50+kIHNZLN++b61pO3BNY6tukY+pqGWkaEZ5FVLlvMuwPSp1OFyarQLvmZqBmgjYUVatHIcVTzgYqe2yWGKaJZ3Hh6bEqV6NbtuhU+1eWaGxDLXpumnNqma9DDvQ8rFLW5aooorpOQKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAA8VgavOMsewrbuX2Qsa43XLjCNz1rKrKyNqMbs5nWbjdI3NYErZJq5fSbnNUHPNebJ3Z68FZDSajkNOqFjukAqSyzbLhST3qwGwcVAWEaCn2yk/O1NCLS0GlHSmmmIa3Q1Hpg3apHntk/pUrdKfokROolvQGplsKWx2E7eXpwH96pzKll4f+0SnEcZMjn0AXJqrqny2kKisT4oX0ll4Ft7aA4mvpfIHPO0j5j+Qx+NbZdT9riIw7nmY2XJQbPELx3uXmuXHz3DtKfqSTWFa2sraixKHA+VfeugupUilCKeIwFGPaliu2UExBAx/iCjNffV8HCvOnUlvB3R87g8zq4OlWpQ2qKz/AK+8vaFrGoeHdT+16XP5FwFMbZUMGU9QQevQVoQ3OseMdeA85pryX5WnkGFiX2AGFH0qh4b0eXX9VW1R/LjHzTS9dq55x6n2r3Sy8PadoEtjY6TFtU7WkkY5eU56sf8AIrnxuJpYeWi99rf/ADMcPSnUjq/dPK/iT4Ki8IHTDb3ctyLpH8wyAD5l25Ix0B3dOenWoP7Gsl+Gh1BoR/aLXSus2Tny92zbjpjPNbXxn1Yaj4iltkOYNPQQA54MjYZ/yAUfhT7mAN8JbNkHDW+4/VZif6VFOrV9hRdR6tr/AD/IucIe1moLRIqfB2ADxrcIDyq4A9gw/wAK7b4gJjxID6wqf5j+leffDPUUsPiPZtJxHd5iz7sOP/HsV6R8RVxrlu3rAP8A0Jq8XPk1XTfVI9bJGrNHO9qjkOFNSdqhnOEavBZ9GilK+InPtWVAckfWrt2+LdqpWnLCoZqizcHEOB1NPtIyQAvWo5cvIqivXPAPhOOxtotQv491243Row/1Y7H6/wAq1pU3UlZGFasqUbs57QPA19fKs12Rawn++MuR7L/jXa2HgzSLQAtE87jvK39BgV0lFehChCPQ8ueJqT62KkWm2MQAjs7dQPSMVaRFQYQAD0FLRWqSRg23uFFFFMQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAUdVk2w4rgten5IzXX63LhiM8CvPNduAXYA1yV5HdhomNM25zUJ5bFBbJzTYzudj6VwnpWGyHBNRQjLk0+U9aSP5YyaBitmSYKOner8YwAKpWa8Fz3q6vSmiWPJpKaaUUxDq0vD8Y892x1wKza2fDyFpMjpuqZ7ETehp6y3zwRjua82+LmqNJrkForZj0+1ACjtJJ8x/8d216RfjzNZt07d68b8RRHWfiNdWatxc6iLbPoAwT+lexw9TTryqS+yjws4m1RjBdWc/r+hLbW9i1wzNJNaC7kXPC7ydo/wC+QD/wKsnwqW81Y3JaNmKjPpiu2+K06N4o1xYQFigKW0ajooRFXH5g1zOl2LWelaRevnFy0rD6KQP55rPKMVUxGaSm3vf7uiPr8/wNLC8O0oOKulF/N6v9T0f4OQGb/hIFUfNH5Lg+3zgj/PpXa6rrI0Wyn1Of53gTbCh/ikPyoPzOfoDWT8BdPcaTrd64+S5kWFf+Agk/+hj8q4r4ha4L7V/Jt2/0a1Ygc8M/Qt/QV7kqf1rGzh0Vr/cj87U/Y0Iy6nO6lM7DbI5klLNJK56s5OST+Nel6dEbj4X21sFywspsD6l2/qK8mnz5ZY/xdD617fpEQsPBd00oGYNIkfB9RF/9euzMXyRgl3MMInKUmzxK1unt7myulOJIXV1PuDkV9AePyJb+zlTlWi4+mc/1r532M6wRr952AFfQvjNPLubdM5EaBM/QCvN4iStTfr+h6mR39pL+u5zhqreNthJNWT0rO1R8Iqjua+WZ9SjPvD/o5qOxHOaddcwEe1JYfcqOpp0Ol8D6amp+J7WKYZiUmRge4UZx+eK90ry/4S2e/UL27YcRRhB9WP8A9j+teoV6WFjaF+54+MlepbsFFFFdJyBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFBOATRTJ22xMfagDk9dmJZ8GvOtXlJmIzXcazJw5rzzUn3TH6151dnr4aOhDu+Umi0bMTN6moS3yNRYt/og/wB41zHXYlc5NJIcIqjqaQNgkntRa/vZS56CgTLsS7VA9KlzgVGWwKFOeaokkFKKbThQA4V1HhaLKqfXJ/WuXFdr4Tj22+4+lDV9DCs7RIIwZvEoHYcV5TokKx/GYRz9F1ab897EfrivXtAjM2uyynoCa8H1PUZIPGl5q8K5kj1J7hAe+2TIH6V7uQQc1WS6qx4OcTUXTv0KHxCufN1rxBL2e+mx9N5xV/WUaDwp4RiZdoFrK4PqWlY/yK1yeu3pvhLI42yyzl3X0JOa9h8a+H2f4b6VdxjEmmRQ7h6qyqrf+PbTXmcPL2WNvU03XzZ93xvUjLLaVKm7p2at2Sf+ZqjWYfDXwUsTZsovL9GiiKnkOzNvb/gIzz64rjvhfpS3muW9/dRq9nbSqoDjId//AK3X8q4wBTsEjlY8gFuu0E8nFe46vqXhzSdNshpN9aGxghAjWKUOxxz0HO4nrnuea+srU3hoypwu5VG3f9D8wpz9s1J6KNjgfF2jxX/xJn0iyUJHcagqYUYChgpc/gSxrqfizff2Xp8+m2pCteOIQo7RDBP8lH4muAstbvrXxQviLy43uPtD3GyTO07s5H5GovEXiC413VZNSvvL81/lRYxhEHoK2WGqSqU+b4Yr8SPbRUZcu7f4Efh+x+3eLdKtFGVWRWcey/Mf0Br2vxh80qN33H+Qryf4YSKPGqeYRueGTbn1x/hmvSfiBpKahLE8txfQ+XhQLe5eIHI7hSM9K8fP3epGL6I9TJdHdGS1Y2qN++Ue1Rt4bt/+f/WP/BhL/wDFVk6j4fgWdcXuqnjvfSn/ANmr5x27n06cuxokbkINJYDtWTDoEJ/5fdU/8Dpf8aSHQIRKR9t1QfS+l/xqbLuW3Lse8fCmLbo93J/en2/ko/xrt68o+G3hK1utEmZtU19CJyMRarOg+6vYNXW/8IRZ/wDQY8S/+Dm4/wDi69Sj8CPExH8R3Oqorlf+EIs/+gx4l/8ABzcf/F0f8IRZ/wDQY8S/+Dm4/wDi61MTodTv7TStOub/AFG4jtrO2jMss0hwqKBkk1meHfFek+ImK6XLcl/LEwW4s5rZnjPR1EqKWU/3hke9N1zQReeD7rRI0ivUlh8krqckkqyKTyHYHeTjPOcg4rwXxp8M/E+k+ENWSzSebT5rizW08P2l9camkRWcM8geSNWUY4wFPHJJxQB9MUV8/wB78GPEVzptwsN5pNlBLrR1IaDbvmxWLaF2ZkgZS3GeYCue3TF3Rvgk39q+FP7cEdxo2j2k8LWz6lLNIHM3mR7XSKEMi8cEADgYIGaAPc6K8A0z4H38N3ost8uhTLBcaq9/95jcxXC/uEOY/nCN8xDcDqMms7XPgr4y1PwppGkSXnht5bHTFtEuiuJ45VlLriZrd5DGBgAI0WMnqOoB7iPF2jPda3bQT3FxdaK0aX0NvZzTSRmQZQBUQl8jn5Acd8VvKQyhhnBGeRg/lXg2ufBvVrqTx59kh8PvL4jt4BDeyu6TW8qhfNBAiOVkYFiwYEnBIOeOp8P+AdQ0rx/qGs6hY6HrkV1NFLBf3krC705VTaY4VMTAqD0w6dTmgD1GiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAqrqLbbZqtVm62+23xSloioK7OI16UKjc1wd42ZDXSeJJypIJ4rk3lDHBNeXVd2ezQVkI33DTbBv9GPsxpz8rVWyfHnR9wc1idBNPLhCo+8TirtqojjVe+Oayw2+8jXtnNXzLtVjTQmiwH3yYHQVYWqNl/qtx6tzVwHC5NNEkgNPWo1qUUxD1GWA9Tiu80hfI0tm77a4izTzLqNfU13F032fSCO5GKG7HNW1aRVsbxNL0bU9Ulxtt4Xkx6kDgfj0r52vX8tI/NbMjZdz6knNev8AxE1Iaf4LgsQcSahLhv8ArmmGP6lf1ry6z0wX2ha9rF2u6C3RLeAZ6yuwH6LuP5V9LlMo4LBTxdTb87f8E8LE0JZhjqeDpvWTS+8wp7O2vyhD+VKpzzwDXd+I/HN3qWkS6eIbe2tZQFdUYuxAIIAJxgcCvNtLhePVpLUOSm0MAT0rv/h14cHiDVL6RwHisI1kMZGd7E8D9Cfwrvw1TC4ml9fcLN/o7L/hyM1w+LwNf+zZ1OaMNvmk3bt6CeGfAmv+I4jcW0EVnZkZWa7JUP8A7oAJP1xj3qjPpUuia02n36wOcbhLHyrj1BIHoa9khvLmO0NssrCPpgdfpXm3xaH2LW7OBOZ0tQzgdQWY4H14/WtMNjKtas4StZ7HnVKEIU7x3E8F+H18T6qbjUxIuiWz7GRODM393Pp0yf8AI9I1O306HQtc32sEdhFZTFYggCjj5cDsc4x70/QdFPhnwdYLfusZji8y4LcbGYliCfbOPwrzDxx4qk1ZGsbPdFppcMxPDTY6Z9Fzzj6Vy+/jq3uP3U/lv+bNny4eHvLU5bQ706ZrunX3OIpFLY7rnkflmvoLxkoaIumCu5WBHfqP6185TrmM+3Ne66ZeHU/h1pd25y/kiJj6lH25P/fOfxpcQUrwjV+X6muS1P3nKYr1kaovzIa12FUNRj3RE+nNfIs+wRStxyaVlxOPei361LcLja1IpnqXwncHTr1O6yKfzH/1q7uvM/hRcbb67gzxJEH/ABU//ZV6ZXqYd3po8XFK1VhRRRWxzhRRRQBx/jrxjL4c1Xw9pNhpyX2p65PJBbie5+zwJsXcxeTa5BwRgBSTXKeJPi9ceH7rWkvfD8Tw6CbNNUeK/JdXucbRboYgZQMjJOzPYV6brOj6Zrdp9l1rTrPUbXcH8m7gWZNw6HawIzVIeEfDYuLKf/hH9H86yVUtZPsUe63UdAh25UDsBigDzbUvjPeWCeL7yTwjNJo3h26kspL1L9P3swdERPLKhl3GQEnkKB3PFX/hJq+tal8QviNDrkrK1tPZCOzS8e5htt0JJWMsq8HgnCjn1616H/YWkfZr+3/sqw+z6g7SXkX2dNtyzfeaQYw5OOSc5pNF8P6NoQmGh6Tp+mibb5gs7ZId+0YXdtAzgE4z0oA06KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArF8QvtT8K2qikt4pG3SorntuGRUyV1YqD5Xc8g1iKS7dkjheU+iqSf0rnpvDetDLQ6beuv/XFv8K+hFRUXCKFA7AYpa5nhU92daxrjokfNdxbX9mMXlncwD/ppEy/zFUUk2XYbs3FfULqrqVdQynqCMiuY17wNomsIS1qLaftLbgIfxHQ1nPBv7LNoY9bSR4XBzfZ9AaluH+UKOpOK1vEnhq88NanEtz+8t5MiOdQdrex9D7VkRDzLpR2HJrkcXF2Z3xkpK62NOLhQB0AqWRuFHqajQdBSt804UdqYmW0qUVHGKkqkQaGhpvv044FdNq77oY4h/Eax/DMWZS+KvavcLDO8shxHBG0jfQDNZyu3ZHNN+832PIPidqLX3iKVEbMFggtkx03dW/U4/CtjXrH+xvhH4fsXyLjUL37ZIPUbDj9ClcvHZzavqem2PW61C48yQ/7zZJ/Lmt34sX8q3+n2DkhLGB2VT/DuOMf+OCvpM+th8BDDx6W/wAv8zn4PpvE5xGq+l39yf8AwDznS51XxLcFzgH5c/pXrvwHvIrTxLqdjKwEt3Crx5/iKE5H1wxP4GuQ+F3huLWvDXjPUbhAXgtf3LkdHBMnH/fsD6GqOn3c2nX9rd28vk3luwkil7Z9D6g9K1yaP1rLnQ6q/wDmvxM+LZRo5xKovK/3f5HvWsCLTNRmmmwlvF++Zj0Cjk14hc6/9s8ZjXrq3NxH9rW48h2xlFI2rn2AFanjXxrqHiGERzrbW0JUeYIHJMhH16D2qJ/BuoweFLfXLnyUtp3CqmT5ig8KxGMYJ9+4/D0cJh44eN67tKWh83WqOo/3Wy1NHx94+n8SBIo4mtNNj+YQlstK3q2Ow7D8fTFvwH4KtNQuoZvE8byfaB+7gDlAoPQkgg59q4nwzp39seMNJ02T5o5bhRIPVAct+gNe4X7G21xmUYEUoYDpx1qcU44aKw1DTS5VK9V+1qank3jjwv8A8I14iutPjZntnTz7Vm67CSCp9wQRXXfDG5N34A1C0Jy9ncE49FYZH6hqX4w3K30+nahEmEt38gnuVcd/xH61m/B6RV1bXtOJwJ7cSD/gLY/9mrLEuWIy68/iVvw/4Bth3Gji1y7GuRUEy7lI9asupVip6g4qGSvj2fZIx4l2uR6GrTrujNR3C7JCfWpojuSpKOh+HlyLfxHaBvuyZj/McfrivY68A0ydrS9hmXgxSK4/A5r35WDKGU5UjIPrXfhJe60eXjY2kmLRRRXWcQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHH/FZoV8HTmYAv5ieVns2e34bq8g0+EpHuf7zc/Su7+KmpfbdSg02Ngbe1/eS47yHoPwH864+PmvMxElKp6HsYSLjT16j0HNNthulZjT2O2MmpLVNsY9TzWJ0MnQU+kHSp7NPMuUXtnJqiXpqdP4ei8u3JPWuc8cXW3Rb4htr3DpbJ75PzD/AL5DV1cOLfT2b2NeZ/ES5KT6Vbk8BZLlh6k/Kv8AJq6Mspe2xcI+d/u1PKx1T2dCcvl95Q+HJW5+Kumk/dj8zb+EbYrA+LmrLe+LNcnQjy0k+zJj/YG0/qCfxqPwxrP9geJrHVmjaVYGYsq9SCpB/nXI6vctevHk7pJpC7e5Jrs4qjJVaa6Nfl/w57nh5Ti1XrfaVkv+3v8Ahj2X4aFNH+D2tNINsl5BM6n1yuwD88/nXN+DtJtdb8daVpmoKXtZEYyIGK7tsbNjI56ius+I9oPC/gDR9NBxPPHFEw9CgDOf++sfnXOfBmOW8+JFpcdVgilkkPoChX+bCvWy6mqGAnUjpo/vS/zPkc2rvFZg5S1978L6fgelXvw+8N6bqEcttYZwNwSSRnUH6En9an+JUix/DkDoDNEB/wB95/pXQ6/cQSSJslViAQQvNct4ytD4i8Nw6Ukhtwk6ymUruyADxjI9fXtXmU8WnOnKtO9n6lvDStJU47o83+Dlv9q+JdtJjiGOWX/x0r/7NXqPivEetTjpkA/pWB4B8NL4T1uXUftJuzJA0ITZsxkqc5yf7v610GvH+0bzz1QpwBgnNdOJx9GtiueMvdtYxp4OrCjyuOtzE8VaWLv4c6xdAZki2SIfTa4LfpmuC+F10V+I1ko+7cI8be+UJ/mBXsd+1t/wr3VbNpF802U+VPGTsbH17V4J4AuPI8eaDID1uY4z9CQP613YGft8PWj6/l/wDnrwdKpTb/rU9X1yA2+pzpjAJ3D8aznFdX44tfLukmA6/KadpvhWE6b/AGhrV6tla7d/LBdq9izNwK+VVOU3aJ9XCtFU1KRw1ym5TVa0fBKNXd6n4Ut59MOo+Hb+PUbYAn5HWTcB12svB+lcHMNkoYVnOnKm7SN6dSNRXiWVGHNe1+ELo3nhuwlY5YR+Wf8AgJ2/0rxZCCM+1ek/C288yxvLRjzE4kX6MP8A6361vhZWnbuc2MjeF+x3FFFFegeUFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVDXNRTStLuLuTB8tflUn7zdh+dX68t+I2ti81AWEDZgtidxB4Z+/5dPzrKtU5I3NqFL2s7dDkLuV5pZJZW3SSMXYnuT1psI+QH1qFzuYD1OKsEhVryz2hsnzuqDpV1BgCqdsuWLmri00IfWlo0W+Utj2FZ1dJ4ftjlcjpRJ2RlUdkX9SO22SIdWIFeJ/EK/Eviy86tHbhbZV/3RyP++i1eyX86Jes8xxBbIZXPoAMmvC9Cgk8QeMtOil+Z7y7Ekv0LZY/lmvd4dppSqV5bRX/B/Q+fzid4wpLqyvrFlLYkQ6jY3FjMyhlEqkBh6jNVPBmkfbvHuiq4UwfaUaYH7u0MCT+QxXp/xds9U8X+OYNJ04tBZ6Yiie4YfIrOAx4/iO3Zx/Kt7w9oVpolssNjEu/GHlI+Zz7n+nSjF5vQxuHdOrTfMnp/nc78JgcTlNWFahVXvR1Xk9k1t5rU0fiFo2m+KrvTzPLMUs/MG1DgPu29/wDgNQ6XpFnpkZi0+2jt1IwSg5Ye56n8a04Ysjng1MFyNpHzCvFniqkoKm5PlXToXChCD5ktSokRzg9akEYDj361aZfunHNP8klwQO1Ybm1ykYxhsU3buwPUVNcI0TFWHWoUJLADtQFxduCR6VlXWgabcX1vevaRrdwSLKkqDa24EEZI69O9OvtWurS7liTQNYulU4E0CRbG47bpAf0qofEVzjP/AAjGvY/3IP8A47WtOVSm7xdjOSjNWkrnX608Or6c2wbZ05KH+ntXlv7Wt1djSfDUEDuumTSStKqnCs4CbM/gWxXQL4huwwP/AAjOvA9iEg/+O1X8azv448GXehXXhjX1ukAltZligJjkUfKcebnHJBx2Nd+ArKnVTkFNqnOMuiPKvgr4lbwh4ntpGuHTS7wiK7jz8oB4D49VODn0zXr3xA0gabq7tCuLe4Hmx+g9R+f6EV8w21zcWUs1jf2N3Fd27mOSNo/mVgcEEV9Eaf4xPif4X2Tvo+sz3unfupZo7XcnyDBy2e6lWPvXoZpRjUgpx3O6s4xnGpHZ6P8AQqWr5T6V1Hw8vja+J4oScJcq0Z+uMj+VecQa9tcj+ytV/wDAf/69TxeJ3tbyC4i0vVlkikDqfs/cfjXgwvFphUtOLifT1FcfaeOUubWKePw74jZJFDArZZBz/wACqb/hMv8AqXPEv/gD/wDZV6x4Z1VFcr/wmX/UueJf/AH/AOyqzpnimO+v4rRtI1y1kkzte4sHWMcE8uMqOncigDoaK8c8Fa/4n134h+J7a4vNel0vTNaa1jFnHp62scQAOyXzB55+qZOD1zVXTfjXcapZ6e02hCxj1e01KS0lttQE00b2isW3I0O1Qdvyt8wz1U80Ae20V80ePvixq2r/AAr1aDQ47u0u7PSdOvrvVGvxFcRtPJGVEYijUOSDhiPLHJ47HtD8U7nT9d1TTI7K41C+fXodGs47q7jihVnj3bt6Q7lUc8ESMT3oA9jor5z8G/Fu88I+Eku/FkNzfWl1qWpxG+e8eUwSxZaO3G5ckNgqpyMeldJr/wAadQ0OHUpL7wpEjaZp9lqF7EdSIdFuGVdijycMylhnJUHnnjkA9oorx2/+KV3Jq0GmzWE2n3tt4nstHnFpeRyRypOjMGLSQElcDlVCt6OK3vBXxGuPEHi240LU9F/sO5SOWWK3vZJlupY0faJAhgEZU8nKSt079QAeiUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFZXiTWItE0yS5k+aQ/LEn95u34Um0ldjjFydkZ3jfxAujWBigYfbpxhB/cHdv8PevHZH9T1qfVL+a9upbq7kLyyHJJ/kPas5CZpNo6d68utVdSVz2qFFUo26lm2Xcxc9BwKkPzvgdKeF2oFUVLBFt57mszUkjXAAqUCgCnVRJPZxebMM/dXk12mlQi2sXnfrisDRrNnMaAcudzfTtXQa7KLezW3Tqal9zlqS5pWRyPiu6Nt4P169J+aSL7Ov/bQhT+hb8q4f4RWN0niKPWvLH2a1R0Ut/E7KRgfTOTXp3iLQ4dS8Gx2NxL5TTzpMcfeKKf6jOPrSWFrBZ2sVtaxiOCJdqqOwr06OOjhcE6MPik3fyVjzamFdfE+0l8MdiVy8sryNks53MfU1ZhiyM4/GpIIwBkc1aiUfeUcdxXj3PRYxYgyejCp4rZpVJH3hUqxlvu9aPPW0IZgRzyKqK77EN9hBEFOWHTqKcrRxuvzDbWdqupoZA0XAPBrJkvGPAzzVXUXoCi2tTb1aaJZ8ZB4qhZMjTbm4Ws15Xc5OTSrN5aYxiplK7uUo2VjrYnheNjkbagjtlYqPXmsCO7JAUH5e9XrfUWjycjPanzp7i5Gti7eQhJcKOgqrHK1rIkyn51bP/wBanrfqUZnHzkVQaTe4FJy1uhqOlmeRftJaFHp3i3TvElpxb6vHsmx2lQAA/ipX/vk1t/s4aj5mpazoU5zbXlqZgCf4lIU4+of/AMdrqfjZpC6v8GLucAPPpzrdRkckFX2t/wCOs1eNfBbWDp3jnQbjPyyzC2f6SDZz+LA/hX1lCXt8LZ9jen+8w8odV+mx6DeW72eoz28n34nKH6g4qtOfmUe9dZ8RrH7J4omkUYW4USj8eD+oNchNzKv1r5eceWTRtTlzxUj2H4Y3/wBp0J7Vmy9s+AP9luR+ua7GvIvhnffZfEKwsfkuUKfiOR/LH4167Xo4eXNBHkYqHLUfmFFFFbnOYR8H+GTq/wDap8O6MdU83z/thsYvO8zOd+/bu3Z75zWV4I+G3hnwfpj2mn6fBcSSCVJbu6gie4mSRizI7hBuXnGD2ArsqKAMC78F+Fr1YFvPDWiXCwQi3iEthE4jiHRFyvCj0HFT3fhfQL2G7hvND0q4iu5RNcJLaRus0gGA7gj5mA7nmtiigDkPEHw78Pazpum6abNLHTLHUE1IWljFHDFNKueHULyDk5xgn1rav/Dmiai92+oaPpt092iR3LT2qOZ0U5VXyPmAIBAPQ1q0UAZT+HNEe5a4fRtNa4a4S7aU2qFjMgwkpOM71BIDdRnimaJ4X0DQZ5Z9D0PStNmlXbJJZ2kcLOM5wSoGRmtiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK8e+IesfbtdliRybe0/dKO27+I/nx+Fet3c4trSadvuxIzn6AZr5pu7uS5uWC/NJIxJ+pNceLnZKJ34GF5OXYld2nl2J1/lWhbRLHhF69z61FawC3i9W6k+pq1aDc5c9OgrhR6TZOEqZRimryx9qkFUQFT2cXmzqCOByff2qGuh8PWBkdWYcA5P1obsROXKjoNHtxb25mkA3EZrntSvDeakUQ9Oh9PetTxHqS2lqYkPzYxxWHptu8aF5P9dLy3sOwqJO+iOeCt7zNCR3mYb2LEDGTVu2QY4IzTLeFlwcZq4EBGSn5VDYDQBu5+UinxyhJAe3enpAXxg5FV72MQKcg801F7k3Wxq3E0X2XzI2CsK5m/v3mJHeoJ7hgMbiRURaG2tpbu8cRwRDczHsKqUuYcYWFjhZ0dpWCxryWY4AH1rGu/ESrJ5elWn2kDgzSZVc+w6n68VXuL2TXtr4MencNHF/f9Gb/CrcFsAoCqAK7KOEVuaoYVa7TtEovrmsA58m0HtsOP506DxM+8LqNkFU8GSE9PwP+NXZrLI6Vm3FoVzxXQ8NTfQxVaa6nQWzQXsW/T7hJR3APzD6jqKf5M6cYJrjZLONj8yYPqOKaz3sA/0fULuMeglbH5Zrnlgv5WbLE90d3DBM55BpNUv7XQ7bzrpw05H7uEH5nP8Ah7159Jf6qylTqt2AfSQimabZo1z5kzNI5OSzHJNOOBe8noDxC6HpvgWGTXPCGuaTftuN5HJuJ/6aqQa+TvD80tpJgZS4t5M/7rKf8RX118P38rUtg4EkZXHuOf6V8q+ILU6f4+8SWfQRahOo+nmHH6V7uXveJ1ZdK8pJn1B8RyLyy0bUUHyTw5/AhWH8zXnki/vQfevQL3/SfhN4ZnPLLb2+T/2ywa4Vl+evn8XHlqtGuG+Dl7XNHw4/leINNbOMXEf/AKEK94r5/wBNcJqdq5IAWVTk/UV9AA5GRWuEejOTH/EgooorsOAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDM8Thj4b1QJ977LLj/vk18+6ZaCFTK/Lt09hXsPxS1SSy0aK0iOGvGKsf8AYGMj8civIZrjJCR8k8CvOxck5pdj1cDFqDfcnd97iNeSa0I1EUQAqvZW/lJublz1NTn5pAvYda50dTJYh8uT3qWmgU9QWYKoyScAVQixYW5nmAA4Brs49ljZEnjArO0OzWMZPO3v6mq3ii7LlLWE/O524FYyldnNJ8zKEbNqOoNO/MSHgeprZt4dxyQaj0+08iBI0AwB1Pc1pxqyKDgEd6VrITlcIl2ngnFW40yQVNRhFbBB5NXI7dgmQPxFOEXJ6ESdiWERiNvMwpHeuf1i4+cqG3LWne3ASFlYA+9cvO5kmwvQmtZvSxMI63Fgh859x4UVzuoStrl5siP/ABLIGwmP+Wrd2+npW1rszRWiWEBK3FyPmI/hTufx6fnSWVmkMSRxgBVGBXThKV/3j+RnXqW91GRolv8AZ55NObrH+8i94yf6Hj8q6WCzCjmob3TZZo4p7PAvLdt8eejeqH2I/pWppk8d9beZGpR1O2SNvvRsOqmuuLs+V/ImrHnj7WPz8n/k/wA7oqSW4x0rNurbIPFdK8HHSqFzCADWhzHJXEGCeKy7pMZrpb2MAmsK9XrVAYc4IqzpzfvRUU460/Tv9cKroB6Z4KJGp2pHqf5Gvnf4vQCz+M3iSMDAeVJP++o0Y/qTX0T4LGdRtfqf5GvA/juwb41azt7Jbg/9+UrfAfxGehl7/ev0PdbY7vgvoR9IIf5VxEnWu2s+Pgtof/XCGuImPBrxsd/GZ1YfaXqys7/vo1U87ga+irGQS2UEo6PGrfmM1832533DP2BwK+hfDbb/AA/prHr9nj/9BFLBvVnPj1omaNFFFd55oUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFcR8ZrXVp/h3qlx4dvLu01awUX0DW0rIZPKO5o2wfmVlDDb0JxQB29FfOuhfEjUzoOsfEG6vrizstZ1OLTdJtLmJri3hjRSrNtaeGOMs4OXZ1A2n1oPxx14+EdK1WWHQbWRp7qK++eOWUiIgKYLZrmMybicHbI/sDxQB9FUV538QfHF94e8FeH9WsUtVfVLu0tpru/heOCySYZaaWPeCoHTaXGCQC3r434Q+IOr+EfDt7/ZUNhcpqfifVPN1SVUW1QqqMuN88aqHJ43SjAHG88UAfVFFfNg8Qa1rnxN0nXL+w0u+uLDwhNq8OmwBbxPOWcofJkSVl8xmQYkXJCnbgnmnJ8cfFbeG73UEsvDkkypatEonj3RvJKqPHLDHcySDG7h2CdOUB4oA+kaK8D8Y/FTxz4X1mPR7/TvDcWoR2q3DSy3CwWt4TJgrFLPPFt2pwTtkO7+EDmrN58WPEcGvXSrbaQdNt/EtrobQmGQzGOZc7xIJCu5SP7pBz+YB7nRXkfww+JWp+KfGl7o+ptpf7uKSeNNLVLuIRiTaha6juHAYjJ2tEh/ke1m8VXccroPCfiKQKxG9Ut8N7jM3SgDp6K5X/hLbz/oUPEv/AH7t/wD49SHxddgZPhDxJj/ct/8A49QByfxmuMajp0GfuQs+P95sf+y1xWnWu397IPnPQegp3jHxTJrXiaW7XQtX8iNVjjUrDnjr0kx1JrOOvTjAGhatn/di/wDjleXVXNNs9mg+SmkzoScDNLAvGT1NYR1y4IA/sHV/++Yv/jlTLrs4A/4kGsf98xf/AByp5Wac6N0VpaLB5lx5h6LwPrXJLrtwzADw/rJJ4Hyw/wDxyuv8K6hNPdw28mhatbIQczzLEI1OCecSE84wOPSlJNIzqTVrHTyOtnaFjxXP6bG13eSXj9iVTP6mrHiW5LOtvGeWO0AVes4YoYEiHRRjPvWCMdkWI1bgcEVOquBlSMehqFQqnhiKmEqrwTx60N3ETw7Tw64qSa6NtEdj7vY1A5EcRlRwT6VhX12ZGO3g+lWm4E25gvrtriQgcHvTB5VpbPc3JwkYyff0A96ZGiohuJ2EcajLMxwBWPcXEusXabVKWMRyinq5/vH+lXSpOtK3Qc5qmh1is11cy3lwuJpjwv8AcXsK6SxtCccVDptp04rp7G2HAxXrpJKyPPbu7sitrPC9Kr6lovnP9ps5mtb8LtWZRkMP7rr0YfqOxFdPFAoUcVHcxBRkUOKkrMqnUlTfNE4y3vr5oWFzYq80Z2SrbyjKv9GxwQQRyeDVS7vZSDnT7sf9+/8A4utXVyLO7S9+URMPKuCeML/C34EkfRie1VrsjBqIp7XNqko6SUVZ+vz6/wBKxy95dEsd9tcJ9VB/kTWVckOCRn8Rit2/PWsO5Yc+taq5hJp7Kxiz8MeeM4p2nricfWmXOR4clucfevwin8QP8as6chMoq76EnpXgZN2owHsoY/oa+a/ildi++MPieYHO25EP/fCqn/stfUPgGH9/JIf4Y8fmf/rV8gXUraj4x1u7X52uL6ZxjvukJ/rXTl695s9PLl77Z9TS5t/hB4bjPV7e34+se6uDvW2xsfavRfHyDT9B0PTQeIowuB/sKq/1rzbUOYyPWvCxkuaq2b4bWHN3bIbNdqr7mvoHwuCPDmm5/wCfdP5V4HApGwV9EabD9m061g/55xKn5ACng1qzDHvRIsUUUV3nmBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVxXxK1xrGyTT7Zis9yMuwOCqf/X6fnXa14R4t1L+0PEN9cF8xiQpH/urwP5Vz4mfLCy6nVhKfPO76GcXCClt8ySBj07VTj3XMh7Rjqa07VQckD5RwK81HrssoPmzUlNQcU+rILmmRb59x6L0+tdfDi3tCx4wKxtDteFyM9z9ateJLkW9jtHBxWU30OaT5pGPat9s1eSY8rFwPqa6ODBX0NYOk25htEDHDt8zH3NbVqGUjPzKe9SKRM64GcfiKSEx/dk6etTuAOuVHr1FV5wsaM2N49VNESSvfYiz5cmVPbNUI4gXMjkKo5YnoB60wt58p2E9elZ/iiTzrf+yYzgzL+/IPIU9B+P8AnrVwg6kuVDbUFdkF3OdXuARkWMZ/dp03n+8f6Vr6fbjgBcCsjw+rNELeYAXEGFcevow9jXX2FttAJr2KcYxilE4KqkptSLllDtA4ratSFxVCEACrCvirMzXSQYqC9mGwiqfnkDrVeaYkcmgCtdsCCCMg1zF3bvbk/YpikeOIXG5B/u91+mce1bt1J1rFvHzmlZMqM3HY5+9vHVlSeBldjgFWBU/icfrWPqc4htpJWBG0E1tahtdWVgGU9Qe9cxqR339jaAkq77jk54Xn+eKpJoG09lYXXM2nhbTLRxgtcI5/3icn+RrT0mLMi074gaeI9BSTJzGgmH1X5v5Aj8aueGUE9tDMOjqGqnohHcWl2NE8Fa9qx4+zW0ko+qIW/nXyp8JbA6h4s0SBl3iW9iLj1XeC36A19GfGa6XSvgdqaE7ZbsRwoP7xeQcf98g15d+zXpa3PjmGZhxZWsk4z6nCD/0M/lXZhfcoymenhPcozqHrHxVuA+s2sIP+rhyfqSf8BXB3I3YrofG9z9q8UXzZyFk8sf8AARj+lYRGa+aqvmm2dFCPLTSLehwC41qwgI+WSZFP0LAV7/Xi/wAPbb7T4stDjKxbpD+AOP1xXtFdeEXutnDjpXmkFFFFdZwhRVXVtRtNI0y71HUZlgsrSJp5pWBIRFGSeOTwO1UvCniTSfFmiQav4fvFvNPmLKkoRk5UkEFWAYHI7gevegDXooooAKKK5/xN4rsfDuqaDYXsVzJNrN0bS3MKqVV9u7L5IIGB2BPtQB0FFVdLvotTsYru2S5SKTO1bm2kt5BgkcxyKrL07gZHPQ1U8SeIdL8Nael9rd19mtXmS3V/LZ8u5wowoJ5PfpQBq0UVQ1/WLHw/o13qurz/AGewtEMk0uxn2r64UEn8BQBforPtdYtLq4tobf7S/wBptxdRyi1l8oxnpmTbsDc/cJDY5xWhQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAMmO2GQjqFNfNALXE3lqevJPoK+mWAZSD0IxXzpDamzkuFfG8SMuR6A4rixn2T0cB9r5DlUKFijGBWjCoVAKp2q5O896vp0rjR3seKkgXfKo7Z5plXtKi8yf6kCrRlN2i2dXosG22MjfWue1uT7bqkNsOQWyfoK666IstI9CRXIaRH509xdsOSdi/SsprWxzQe7NRFIwBj6Vetcf3efaqsIO7ONwrUtgpAwmDUbg9BYnVXCycKfUVR1uSNciDHvitW7uEFuY5Yx04NctOd0uF+7npWklyqxMdXcS22wQy3Uv3YwTj19qxLKJpriSeU7pZW3Mf6Vc8QXJEsFhEONvmyH9AP5/pUulQ9CRXdhKfLHnfU58RO75S7FpyyFJEYxTp91wM/gR3HtV+C+e32pqMJhb/nqgLRH3z1X/gWB7mpYRhasKa6nHqjNVNOWSuixDKrorxsGRhkMpyCPWpA/vWLIf7LkMsY/wBBY5lUf8sj/fA/u+o7dfWtMOCARyD3oTvownDls1syZnqCV+KRnqvK/FUZla6k61jXcnBq7eS9axrqXOaaAoXb5zXM6w0ltd219HG0ghJDqvUqfSt+5eoIoxIcEZFUByPii+0vXg/lfbJr+dfLCpNOiqcbclchRgdgOT+JrtvC/gTTTZWkU0d75zKqkLfzryfYPVrTNJtUmEq28Yk9cV6B4VtQbkzvgRwrkk9M/wCc1nJ3dhnhP7TGnaRpU2g6Fpf2zzn3XU6SX08oCj5U4dyBzv7dq1/gR4K0o+FdZ13UY7shW8uPy72eI4RdzfccZyWA59K8v8b67/wmHxD1nWYctbSTeVbf9c0G1SB2zjOPU19H3FiPCXww0rRVwtzKoMw7lj87/wDjxA+lduJtQw1urPVnSUKMKdtX/wAOzy+Xw5p0kzMy3hJOSTezn/2emN4a0wD7t3/4Gzf/ABdboGBmoJ32j2r5tyl3OlQj2Nn4W+DtHvtUvTPHfERRDBXULhOSfUOPSvSv+EA0D/nnqX/g2u//AI7XNfByIifUpD/cTP4k/wCFen16OG1pps8nF29q0jlf+EA0D/nnqX/g2u//AI7R/wAIBoH/ADz1L/wbXf8A8drqqK3OY4H4neDNQ8SeBofC2gXUdnYzzxR3stxM7yC1DbnCEhiznA+8QOuTXlHi74Ya94b046ZpUC69oV14osdRt7coTJGdrCfzlji2JETt+ZVwB1XmvpWigD5p1H4Z67pWreELRtG03V4ZtX1S9ewCyHTbGOaJQkLP5R2oCCRlBljgAdauXfwL8QSaN4esrnWINTisNNeylt3uBAIpGmaQSQyPbz7cBggIVWwgwwHy19FUUAeCXXwY1qa61G+W503+0pNU0++tbuWd3niSCMLKDIIgdzY7ABupx0E9j8I9cg8c2WsTtos/2fxBLq0mpNLJ9sngdcLCy+Xxs7DeV9h390ooA+cJ/gZ4jl8J+HNLS50K3u9KtriO4nSaf/TxJcmUW0mFU+TtPJ5OScDHJ9N+K3gWbxp4Cs9JtbbSre9tZre4igmBNumwjdGrBMhSuVyE6dhmvQqKAPBr74Pazc+NRrW+yS28yzmtoLW+W3bTfJUAwwsbN2MY7BTEGH3lzyK178E9ZvpfEyH+xLe11a3nINyy39x9odw6N55to5EQFRwWkx25r6CooA8OvvhPq11FZKlpo9jDF4ek0eW007UJLYGRp1cyJILc4DAFjlDlmKkEEtXa/B/wlqXg/Qbyy1X+yVMl00sKafBGmyPaAokdIohI+By3lqfr27yigAooooAKKKKACiiigAooooAKKKKACiiigAooooAwPG+sf2PoUrxn/SJv3UXsSOv4D+leLyjEYFdZ8SdQN34k+zK2YrRAuO248k/yH4VyrjIFeZiJ807dj2MLT5Kd+5LENqirUZyKqr2FW1+VayRux9dD4ZgDvHxyTmudByM12PhiLa6/7IApmFd6E3jW58qzEadTwKzrCDybaCMcELz9af4oP2jVrODsZAT9BV2OLnDDKn9Kyk7tsxWkUiSCNs5wAauooHUlD6ioIwIxy2R71FcXA2nbuFKLsJ6keqXT7djENjvWVHIkMctzOcRRqWY+womd55cVl6/PuZNNiPo8+PTsv9fyrSEXVmog2oRuZ2l3S6rJJehtzSvkjuvop+gxXVWMe1RXOR2DrILmyAWcfeToso9D6H0Nb2malaXaKsMyCXo0LMBIhHUFeoIr1Yvl91nLOnzL2kNV18vX/M104xUgNQK1ODVoYE+6s7y5dOybRDLZ/wDPuuN0frs9R/s9u3YVa300yUmrlwm46boILyG5RmgkDbTtYdCp9COoPsaiuJcA81WvYbac7pokZ+gfow+hHIrIuoIQDiW6x6fapD/7NQuYq1N9Wvl/wV+RLeTZJ5rKnenMVQYTOPckn8zVWZ8A1aMivM25qt2MWSKzt2566DSoiQCRSk7DRqWMPQAZNR/GfX/+EL+F9xDbuE1TU/8ARYufmBYfOw+i5GfUiul8K2ImuvPkH7qHn6t2/wAa+Z/jP4t/4Tb4gzfZnD6Tpuba1KnIfB+eT8SOPYCtcJS9pO72R1YSj7WouyNP9n7wt/bHi60eWMNaWA+1TZHBIPyD/vrB+imvXviBffb9ddEbMVuPKHpnv+vH4UfCXS18H/DSTVZ49t/qA87DDBx0jX6Y+b/gRrn7hyxZ3JJJySe5rmzSvzz5F0O6/tazl0Wi/UpStgfSqmDLKB2HJqWVssQOSasWNpJPNHBCpaaZgqgdya8jc6G7HqPwstfK0Se4IwZpcD3Cj/Emu0qnpFkmnaZbWkeNsSBc+p7n8TmrlevTjyxSPCqz55uQUUUVZmFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHgmsTGfXNQmY/fnc/+PGqTyAVHczf6RcHPPmMf1qO0BnkLH7in8zXjN3Z9AlZWL8PQE1YJ+T61WU5YD3qdvvKKBMsxjlRXbeHSNrGuJQ4ZT7113h5sRkZ70Sdlc56yDUYHbW4pdp2qp5q/CpIyelWXXf1oACismzK5G2CvGM1l3zkDAyDWhcyBFOetZDMZJKSGitcXCadYyXUoy33UT++x6CsXT7eQlpbhi88h3Ox7mobi6OrasZQf9DtiY4R2Y93/wAPatiAAAV6uFo8keZ7s469TmdkWLdQoFQXsEccjTPAk1tJ/r4ym7kDhwO56A+2PTmdSBUm+umUeZWIp1HTd0R26tgvp96HiIyEkPmqPoc5/Mn2qaOe+ziSC2x6rO3P4bP61VntbOd989rBI5/ieME/nURSW2wbSRmjHWGViwP0Y8g/p7DrUcrRtzwnvv5r9U9fmjX8w7RuwD3wc1HJNgVSF1vXO1lPcMOlV5rjjrWqRyvQlubnrzWRcTkk80XNxnvWdJLk9aoCZpfeq08ueKhklrNudD07VLoTXtlBPLgLudcnHpSbsBt2MJkkHFdbplszFI41LOxwAO5rjtO8E6AQC+kWZ+sYrqp/CPgrwt4XvPEHiDRLAW8Me5UMQyewAH95jgCsknN2RSTeiKnx18YJ4K8GLoOmyj+29UQp8p5iiIw8nsf4R+J7V4r8HvB7eJvE9pYspFqn765YDpGvUfUnA/GuNvEh17XLvUpbG3t45nLR28SAJEnZQPYd+/WvpPwV8OPD3hbwAt9rujWdxqt2BIEmiBMZI+VOfQcn8a9ST+qUddz1kpYWlyr4n/X4HTfELU1lvI9Ot8LBaj5gvTdjp+A/ma4a6fjA71mS+FtB5Y6TZ5PP+rFVB4W0NnJOlWmP+uYr5mpJTk2y6UHCKikbMcYXk13nww0jz7uXVJ0+SL5Ic92PU/gP515Q/hfRXkSKLSbQyOdqjyxXtej/AAw8KWWnwQzaFp8siqAztEDk9zWuHgpSv2McXVcYcvc7iiuV/wCFd+D/APoXNN/78ij/AIV34P8A+hc03/vyK9A8o6iRiqMyozkAkKuMn2GeK4rw78QU1zxPqehJ4c1uzutLMYv5LlrQR23mIXQsUnYtkD+ANjvitrR/CHh7RrwXelaPZWlyFKiWKMK2D1GawR8O4X1jx/d3OoytB4tght3iij8trZUgaIkPuO4ndnoMdOaAN+Dxh4auLO8u4PEWjS2tmQLmZL6JkgJOBvYNhefWsK6+KvhCHxJomjx6xZ3MmrLI0F1b3ULwIU4Ad9/BZsqoAOSCK42y+BiW+nSWs9/pl7IbeG1W4urW+eQRxMCnS+AUjAx5YQDnAwcVtad8MdUstS8KapJ4tnv9U0N7rdNf2zTieOfAZBmXeu0D5Szv75HFAHUW3jzw8dHttS1PVdO0mC4kkjjF7qFsNxRirAMkjIenQMSO+DxXTxSJNEkkTq8bgMrqchgehB7ivGT8FLmHR9Os9P8AEcdne2RuPL1SG0niu4xNM0jBGjuVUDBxhlcdT3xXsdrE0FrDE8rzPGgUyvjc5AxuOOMnrQBLRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAfM+rh4tVurccOJ3TB7fMRWnbxiKJUXoBWn8QtK+weN55QP3NyouF+p4P6gn8azFbFePKPLJpnvwlzwUkPj/wBdU7feqvbnLMasN2pIGWF6Cui0W4CMpJ4bmubjOVqW1vBaz7LltsEp+WQ9Eb0PoDVcvMmjCtokzv8AzgRwaje4AHWsRZ54gONwppknmONpUVhymVi5czmVwqmuf8X3Rg042Nu5W7vFMYKnlEIwW/oP/rVa1TVbXRYA07CS5cfu4QeWP9B71yCTTXN1JeXj77iT8lXsB7V1Yag6j5nsZVKvs9tyzoE4W3FvKNtzB8sg9f8AaHsa3UuAB1rnZo1mKuCUlX7si9R/iPakF7cQ5FxGXUf8tIhn816/lmvTTcdJGE4xqPmh93+X9X/M6b7SPWl+0j1rmV1WBjhZGZvQKSfyxU32w4zskx9KpST2M3TnHdWN43I9aabj3rC/tCIfecp/vqV/nTTqER4Eq/nTuhckuxsSXIx1qnPde9UHnJ71A8madySeWbdVd5KjZqEUuaVwHopc1r6dakkHFR6fZliMiu28MaGb2UM4K2yH529fYVi25MrYt+F9IRka9vdqWkILEucA46kn0Hevnf41fEB/H3iFbLTHYeHrFyIeMee/QyEenZfbnviun+PfxOXUGk8JeFZ8WEWYr64iOBIRwYlPdfU9+nTOeF+Gfgq88V63FY2gMcS4eefGVhT19z2A7/nXqYWgqa9pM9TCYdU17aodp8CPA41rWRquoR40nTmD5bhZZRghfoOp/Ad69G8aa7/aupEQn/RYcrH/ALXq341oeIbqy8O6JD4b0FRFBCu2ZlPJ9QT3J6k1xIyxJNePmGL9tOy2RpG9WftZfIczbutQysEQ9gKe7YFU2YzyhR9wHk+teabnVfDfTDqPiKO4lTMVuPNPoCPuj8+fwr2auY+H+kHS9DV5Rie5xIwx0H8I/Ln8a6evTw8OSB42Kqc9TTZBRRRW5zhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeU/FyXdrljFnhIN35sf8K4iR9orrfiqT/wlkQPT7Mv82rirpsA15Nd/vGe5h1+6iX7NsxFvWrsYVx8zbffGaoW/yWyj2q3aSKUG4Zx71CNGXooocczFj6Kh/rVoR27xMhhyjcMznP8A9YVXSeFV+63qelQ6Hrlnq0lw1izSQQEL9oCkpIxzkRseGxjkrxz1641g7aowmk1yske0v9NXGn3RWLqI3G5ce2en4VQutU10gr9phhHcxxDP65rphIsq7CvzZwGJzz/d+tZ17Z5yMYNdcY05+80efNzpvlucU8WyZpZGeWVjlpHOWJ+tSJPzWrdWJyeKybi1ZGyK7I2aOdluK4z1qYSg96xwzL1qQTkd6LCNRmV1KsAwPYjNRHMIzCcqOsZPH4en8qpicmlMxqWilJrQuCcMoZTkGmNLms/zikmD91jx7H/69ToS1FxNWFyyE+Xgqf4c4x9KUNKx4jH4tU8UJbtWjbWJJBIqW7DvfdGasM5wRErD2fn9RWnp1vvcB4ZUP+0vH5jIrVt7QKBxXW6F4d3R/a9SIgtEG4hjtJA7n0FRq2VdWtYqeG9AkvmDMDHbKfmfHX2Feb/HD4rR28EvhHwXKAMGK8vYiCAOQ0SH19W/Ac9Knxi+Mn29ZfDfgWTy7IZiuL+LjeO6xEdF65bv245PlvhXw3d6tqMFjpts9xdynAVRnHqxPYDuTXp4bC29+oejhcJb95VE8JeG7vWNSt9P02BprqY4VR0A7knsB1Jr6ksbKx+G/haPSdMZZNUnG+e4xyzf3iPQdFH/ANfLPC/h/TfhjoBZvLutduVHmSep9F7hAfxP8uU1C7nvrmSedy8shyzGuLMMdzfu4Gkp/WJafAvx/wCAV55GmkJJJJOST3NMdgq07btFQSDca8Q3RXlZpG2rXW/D/wAP/wBp6kssqf6HbkM5I4duy/1Pt9axNC059W1aGwtzhn5Z8ZCKOpNe46Rp1vpVhFaWi4jQck9WPcn3rfD0ud8z2OXFV/Zx5Vuy7RRRXpHkhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHmXxg09hJZamgyuPIc+nUr/7N+VeX3Em+vpLVdPt9U0+azu03QyjB9R6Ee4rwHxx4bu/C0rPdEGwySt10TH+16H615+KpNPnWx6mDrJx5Huhw/1P4VnXet22lyJFIHnu5f8AU2sK7pJPoOw/2jgDuazE1K/1qHZoa/Z7Po2ozp97/rkh+9/vNhfTdWho+k2ulh2t1Z55TmW4lbfLKf8AaY/y6DsBXPa251XcvhHRaZe67h/EjJFZYz/Zluf3ZH/TV+sh/wBnhfZutdZZqqqgRRHGi4RUGAijjgfpWcj5X+dXbeQM2CSE6n6AcVXNcXKkbFjC08yrHGzsx2oidWPp7D1Nbx8L6pJEXlNtu6iNWOR7Zxim/Dh0uL2+lYDzEjVYx6KSc/yFeE/EL4n+OLfx9q0enao+n29lcyW0NssSMu1WwGYMDuJxnJ9eK9LB4Z1ldM5J05VpunHoer39jJBK0VxE0bjswrJubENnArB8K/HyG6SOx8f6Suw8G+tFJA92j6j6qfwr1PTbLQfE9mbzwtq0FzD0IR94U+h7r+NbVKE6W5yVKM6Xxo84n0zOeKpSaYw6CvRr3w7f25O+2Z1H8UfzD9KyZLQBiGXBHYis+eSMrI4k2Eg6ZoFlIexrsWs1PamizX0o52wscqmms4wy5B6girUGkzR8xMCP7snP6/8A666u006WdttvA8h/2VJrdsfCl7NgzBLdP9o5P5Ck02OMuU4q0tpVIEtuPrG4YD65xXRaZpFzetttYSwHVjwo/GtHWtT8GeC493iHVbf7QBuELNuc/SNcn868j8aftBahfI9l4JsPsEX3ReXCq0mP9lOVX8c/QVrSw06hvCjOs/cjZHrWual4a+H1it94mvozcEfuoFG53P8AsJ1P1OAPavnn4k/FXXPHzvZWqvpuhZI+zo3zTDPBkbv/ALo4+tcpDp2qeI9ZEt091qep3LfxEySOf8/lXuPgT4KLDDHqPjKZba2UbjZo+Dj/AG3HT6Dn3FehGlSwy5pvU7oUKWFXNUd3/WyPL/h94A1TxPdiHS7fESEedcycRxj3Pc+w5r6L0fTdD+GumNaaaq3eryL+9ncDc31I+6voo/8Ar07UvEttp9kml+GIEtbSIbVdF2gD/ZHb6nn+dcfJIWYs5JY8kk9a8vGZi6nuw2HJzr/HpHt/mS6jeT3909xdSGSVupP8h6CqZIFNlf0qs2415DZulZWRJNMi9WqlLNJKdsY2r61IUUHLda7zwV4Ma7Md7qiFLX7yRHgye59B/OqhBzdkTUqRpq8jU+FegtY2Mmo3C4luRiMHqEHf8T/Ku+pFAUAAAAcAClr1KcFCPKjxKlR1JOTCiiirICiiigAooooAKKKKACiiigAooqq2o2S6kmnNeWw1B4jMtqZV81owcFwmclc8ZxjNAFqiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiquqajZ6TYTX2p3UFpZwjdJNM4RFHuTXJfbte8X4XRxPoGgt97UJ48Xlyv/TGJh+6B/vyAn0To1AGp4i8WWulXi6ZZQTarrsib49OtMFwvQPIx+WJP9pyAe2TxWFqPg+98Q6fdXPjS5ivJvKZrbS7ckWds4B2sc8zOD/E/A/hVetdZ4e0DTfD1m1vpVsIg7eZLIzF5Zn7vI5yzsfUkmtQ80mrqw07O585xn91jGMUkLBmK9+tbnjDRm0bWp4gpFu58yE9ip7fh0rmt+y4B/CvHknF2Z70ZKSTRooxU1Mr8HB69aiOGUEU1GxQUbOgaxNo2opcxAMMbXQ/xL3FanjTwXofxHiOo6TcR2euKmDvAHmY7SKOfbcM/j0rls5HNOgmmtpVlgkdHU5DKcEV04fFToO8TGdJuXPB2Z5Z4u8Da34clddX06VIgcC5RS0TfRxx+Bwa5S3W8026F1pV3cWdyvSS3kMbfmK+rNL8dXCQ/Z9VgjvYSNrE8MR79jVHVPCnw78S/MsbaRdN/FB+6A+owUr3KOaU5q0yliJLSrH5rU8d0T42ePNIjWOe5tNTjXoLyHLY/wB5SpP1Oa7LT/2jt6hdb8Kh2HV7e4BH/fLL/WtC8+BFvcDfo/iOGUEcLLEDn/gSt/SsO5+AXiJSfKudJlH/AF1cH9Ure+Fqa6fkZv6pPey/A6Ff2gPBzjNx4b1QN6C2hYfmXFMuP2hfC0an7B4Y1F27CSOKMfozVy3/AAojxTnG3Tsev2g//E1oWP7P+uOwN3faXAvfazufy2gfrU+ywy6keywi15vxK2qftF67OCmh+H7GzXsbh2mI/AbRXEa98RfHPiNWS81qa2t26xWn7hcemV5P4mvYrX4E6NZqG1bxC/H3vLRIh+bFq2rHwl8OND/5djqMy/xTM0ufw4T9Kl4jC0tv6+8qM8PH+HG/y/zPmXSfDN7q14VtLa6v7pjlhFG0jH3OM/nXqOk/BrWrexjv9WtCluGG+1gniWfbzyWdgijp3J56V64fF1vYW/2bQNLt7OAfdGwKB/wFcCuc1HVr3UW3XlzJKM5Ck4UfQDiuWtm3SmjR1as9IrlX3sNF8SWfhGze18PeB7tbjGGne6t2Zz6s4kJI9hx6YrG1fxb4k1eXfc6LNtHRGuolUfQAn8zVhpVHU1XkuQPujNeRUxEqj94iNBRfNfUzW1TWR10L/wAnE/wqBtU1qQ4TRYl9TJeqB+imtF3kflgcelQO0uMKuBWPMuxsovuUX1LW166Raf8Agef/AI3VWXVdbJwmk2QP+1fnH6RGtQQySH5iavabpcl3cxwW8Rkmc4VRRe/QGrdfyK3g3T/E+s6zFs0jR5Y4f3rpLqcqKQCOCRbt/KvZlu/G4UImgeGox0Df23O2Pw+yDP5ir/hHQI9C07y+GuZcNK4Hf0HsK3a9KhT5I67nkYir7SWj0Ryvn+OP+gd4a/8AA+f/AOM0hn8cY40/w0D6/bpz/wC0a6uitjnOV/4rj/qWv/I9Vfi/oUGv/DbxBDNpUOpX0en3D2cZtxM6z+UwUxDBIfPQjmu0ooA8RsItZ8E+H/hnH4f0a5srC5th/wAJBFY6V5khmNqgRplVC4bzActgHI+Y1gabr3xavtBtHuZNctL1fDd5eyEaPGGkvo7mQRRFWhOGaMINgAJBBAyc19G0UAfPWoap8RIry+1TTdEmivbjRdLa4uY9HTz0dubjZlN0jpniJi2P7tavj3xF4ttNItIvBs/jO+uXguZBfXOkpEPMUDbHJF9hLZz935YlOTl/T3CigDznxDf+Mp/g5YaxoyzW3iyKztr24s/soLTsFUzQGNlJUnLYAAbIAFcZqfiT4i/8ItY3v2XxDBqWr3V3PBFb2Ue3TYQP3EM6i1mkJOM52jlvmYAce80UAfNXiXx18R9P8Mx6nq76poaxeHxcpLDpSsst/wCZtK3BeJxD8vIU7ASRzyBWldaj46gvvEd9otjdRT3c+hbLu20eMvcRvB/pLF/KPmBScEnOzoNo4r2zVvDOg6xew3mr6Jpd/dwALFPdWkcskYByArMCRyc8d616APA7/wAR/ESztNSsGh8S3FxHrd1aWWpQ6fGoNsqKY3mC2su5SSQGjjAJBywFc3qq+N9bsrPXNT0C+n1tvCF1BMkuk+YrXH2sbUaFkKliqhthXnrjFfUFFAHilhrnjaHx9pNm0eqz6HIbaFrez042sdoojHmNM0tqVdd3/PKZSOgFe10UUAFFFFABRRRQAUUUUAFFFFABRRRQBzWreOPD+lavNpl1eSte28YmuI7e1muPs6EZDStGjCMY5+cjjmuigmjuII5oXDxSKHRh0YEZBryXWvA/jbTdd8T3vgTWdPtF1yeO7M1ywWW3lVNhUhoJVkjI5wNjAgfNjOcTxD8JfFOoarrDxXujzW+o6pp+qPPLLJFIrQJtkXy1jKncSSDuH054APWPB/iux8VprDadFcxjS9Sm0ubz1UbpYsbiuCcr8wwTg+wroK8H0/4P6/H4te/afR7KP/hI7vWl1O1ldr0wyjC2+0xgAdz85HPQ98Wz+BHiK30TVbNr2zkv7uwmsze/b9iXG6TeGmiW0Dsf9ppnIxxxwAD6Sorw3U/gdE01nFp1vpgsI9Eu7OWK6llmLXswyJgXDHAcBs5BHUCsfxd8GvGOuaJpdkl54e+02Ol2ltFekbbhJ4iCxMxt3lZODt2vHjPIPOQD2ZPCdvca82ra3cy6rcRSmSyinAEFkP4fLjHG8D/lo2W9CBxVrxp4ks/CPhfUNe1KO4ls7JBJIluoaQgsBwCQO/qK87g+GmorqXio31noWpSazJdtBrlzI326ySaFkWJUMRBVc4+WRflJ47HkX+C/i260y7t7q40KKVvC0Xh+Ix3UzhpI7hJBI2YhhSqnpkg+3NAH0TBIJoY5VBCuoYZ64Ip9eEeI/hJ4kvtW1k2Vzo7WOoarp+piSWeRJI/s6bXTYIyDnJwdw6cjnhNM+Cl7Fq2m3V+uiTomsaheXudzG4tZ1+SI5T5sHJKn5eeCaAPZfEGi2uuWJt7oYYcxyDqh9R/hXi3i7wrqOhszyxmW2B+W4jHy/j6GvTPhD4a1Hwf8OdG0HWriC4vrJJEeSB2dCDI7KFLAHAUqOg6V1zqsiFHUMjDBBGQRWNWhGpr1OijiJUtN0fONlcb4V/Ij0p8r7enSu/8AHXglIEbUNBtto6zwR5P/AAJR/QV5w0gZSDkEdq86pTdN2Z6tKrGpG8S/C4dAQakFZVpP5c2xzwelaQaouaDyoNIFI6Gmbjmjzcdc0wsTpvB64q9BqF7Djyry4T/dkI/rWYJ19aXz1HemnYlxT3Nsa5qeP+Qjd/8Af1v8agm1G7mGJrqeT/ekJ/rWX9oX1ppuhnijnfcSgl0Lhek3VT+0H0qCHU4pZUjQSHfna2w7TgZ4PQ0rlWNFiccVEwJ6tVKS+ka7eCCDcUUMzOxQc+nBz0ps073WmiW1k8p3UMpbt/Oi4FsoO9ACjpWLHfSteQNK4CtCx8tCSM5Xk+/JqybsnoDj6UrjNBmAqPcDVLz2PRTn3rvfBHgy4v2jvdXjMdp1SIjDSe59qqEHN2RNSpGmryMPQ9IvNYuBFZRFgPvOeFT6mvWvDPh210OD5P3l04xJMR19gOwrWtbaG0hWG2iSKNeioMCpq9GlQVPV7nk18TKrotEFFFFbnMFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV5t8bfEmv8Ahu28Jv4ce3R77X7Wxn85wokR937skxvtVscuPmXAwDnj0mqWr6Tp2tWRs9YsLTULQkMYLqFZUJHQ7WBGRQB5pZ/Fu7vfGk2h2fhPULqC11JdLvLq3E0nkSEfNIcQ7PKDcZaRWI+bbiua8X/GHXj4S8SCz0qPw5rtlaG7igvpJftaRCdY/M8qS28pwcn7sjDn8vYZ/B/hmfUIb+fw7o0l9Ds8q4exiMibMbdrFcjGBjHTHFJp/g7wzp0F1Dp/h3RrWG6j8q4SCxijWZP7rgL8w9jQB51N8Rde03VruCTRL3V9Qh0G31D+z9PuElid5JtmVxbrLnHzEjcByAnGT3fw98Vx+MNCl1CMWitFcyW0kdtLM4jdMZVvNhidWGeQU9OTU7+CfCr24t38M6G0AjEQjNhEVCBiwXG3GAxJx6kmtXStMsNIsktNJsrWxtE5WG2iWJB9FUAUAW6KKKACiiigArm9e8GaPrDNJJCYLg8mWD5ST7joa6SiplFSVmVGcoO8WeYXnwpVzm21QqPR4c/qDWTrfgrUtFt/NVxe26j5njXDL9R6e9ey0VjLC03todEcZUT1dz53BzSkA1654g8E2Gps01t/odyTklBlW+q/4Vxd94F1m2Y+THHcp/ejcfyOK454ecelz0KeKpz62OTMWe9IYx3Fal3o2pWWTdWVxGo/iMZx+fSqPI6ismmtzdNPVEaxJ6VIEUdhVizs7u8cJaW0szeiKTVq58Pa1H/y4OeOQCCR+ApqLeqRLlFaNmFq7bdMudpwdh5HYd/0qvd3UaXVikeOGbAHpsI/wq5PYT7mju1ZD0KMuP0qsmjwKysAWZcbSxJ249Kh3KKV7MrXsnnvKitEoG0sAeW9KjNreyWaiF3C8oqScHb2JPUY/wAK3obG4mcJAHkc9FVcn9K67w54Dvr1zJqheztwOBgb2/Dt+NVGnKbsiJ1IwV5M89tbKTzfNnVU2psVFbIA78/l+Va+m6Rc6jcLBZQPNIeyjgfU9q9fs/A+iW2C9u9ww7yyE/oMD9K6K2tobWIRW0McMY6KihR+QrqhhH9pnJPHRXwI4zwp4Dt9PKXOqBLi5HIixlEP9T+ldxRRXZCEYK0Tz6lSVR3kwoooqyAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACont4XOXhjY+pUGpaKAEVQowoAHoBikMaE5KKT9KdRQBHJDFKu2SNHX0ZQRVY6TpxbcbC03evkrn+VXaKTSY02tiOGGKEYhjSMeiqBUlFFMQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The testicle is vertical and its anterior portion is surrounded by the tunica vaginalis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32786=[""].join("\n");
var outline_f32_1_32786=null;
var title_f32_1_32787="Diclofenac (ophthalmic): Pediatric drug information";
var content_f32_1_32787=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"16\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Diclofenac (ophthalmic): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?14/63/15348?source=see_link\">",
"    see \"Diclofenac (ophthalmic): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/51/10036?source=see_link\">",
"    see \"Diclofenac (ophthalmic): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8016890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Voltaren Ophthalmic&reg; [DSC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8016891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Voltaren Ophtha&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10484186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Non-narcotic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anti-inflammatory Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Nonsteroidal Anti-inflammatory Drug (NSAID), Ophthalmic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10484193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?14/63/15348?source=see_link\">",
"      see \"Diclofenac (ophthalmic): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Cataract surgery:",
"     </b>",
"     Instill 1 drop into affected eye 4 times/day beginning 24 hours after cataract surgery and continuing for 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Corneal refractive surgery:",
"     </b>",
"     Instill 1-2 drops into operative eye within the hour prior to surgery, within 15 minutes after surgery, and continuing 4 times/day for up to 3 days",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F8017237\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic, as sodium [drops]: 0.1% (2.5 mL, 5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Voltaren Ophthalmic&reg;: 0.1% (5 mL [DSC]) [contains sorbic acid]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F8016893\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10484194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For ophthalmic use only; avoid contact of bottle tip with skin or eye; apply finger pressure to lacrimal sac during and for 1-2 minutes after instillation to decrease risk of absorption and systemic effects. Wait at least 5 minutes before administering other types of eye drops.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F10484191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 15&deg;C to 25&deg;C (59&deg;F to 77&deg;F).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10484187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of postoperative inflammation after cataract extraction; temporary relief of pain and photophobia in patients undergoing corneal refractive surgery (FDA approved in adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F8016888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Diclofenac may be confused with Diflucan&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International Issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Diclofenac may be confused with Duphalac brand name for lactulose [multiple international markets]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Flexin: Brand name for diclofenac [Argentina], but also the brand name for cyclobenzaprine [Chile] and orphenadrine [Israel]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Flexin [Argentina] may be confused with Floxin brand name for flunarizine [Thailand], norfloxacin [South Africa], ofloxacin [U.S., Canada], and pefloxacin [Philippines]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F8016903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Facial edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Chills, dizziness, fever, headache, insomnia, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Pain, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Abnormal vision, blurred vision, conjunctivitis, corneal deposits, corneal edema, corneal lesions, corneal opacity, discharge, eyelid swelling, injection, intraocular pressure increased, iritis, irritation, itching, keratitis, lacrimation, lacrimation disorder, ocular allergy, transient burning/stinging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Rhinitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Viral infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Corneal erosion, corneal infiltrates, corneal perforation, corneal thinning, corneal ulceration, epithelial breakdown",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10484188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to diclofenac or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10484189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with previous sensitivity to acetylsalicylic acid and phenylacetic acid derivatives, including patients who experience bronchospasm, asthma, rhinitis, or urticaria following NSAID or aspirin therapy. Use with caution in patients with complicated ocular surgeries, corneal denervation, epithelial defects, diabetes, rheumatoid arthritis, ocular surface diseases (eg, dry eye syndrome), or ocular surgeries repeated within short periods of time; corneal thinning, erosion, or ulceration leading to possible loss of vision have been reported; discontinue if corneal epithelial breakdown occurs. Use of ophthalmic NSAIDs may be associated with keratitis; continued use may be associated with sight-threatening complications, including corneal perforation. Use of topical ophthalmic NSAIDs for more than 24 hours prior to surgery and more than 14 days after ocular surgery has been associated with an increased risk of more frequent and severe corneal adverse events. Ophthalmic drops may slow or delay healing time following surgery. Patients using ophthalmic drops should not wear soft contact lenses. To minimize the risk of infection following surgery of both eyes, two separate bottles of eye drops (one for each eye) should be used for postsurgical patients; instruct patients not to use the same bottle for both eyes.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F15117524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refractive stability is not established in patients undergoing corneal refractive procedures; monitor patients for 1 year following application of ophthalmic drops. May cause increased bleeding time following surgery; increased bleeding of ocular tissues (including hyphemas) has been reported with other ophthalmic NSAID use.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9811041\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Latanoprost: NSAID (Ophthalmic) may diminish the therapeutic effect of Latanoprost.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F8017290\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F8017291\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have not been observed in animal studies; therefore, the manufacturer classifies diclofenac ophthalmic as pregnancy category C. When administered orally, diclofenac crosses the placenta. Refer to the Diclofenac (Systemic) monograph for details. The amount of diclofenac available systemically following topical application of the ophthalmic drops is significantly less in comparison to oral doses; however, because it may cause prenatal constriction of the ductus arteriosus, the manufacturer recommends that the use of diclofenac ophthalmic drops late in pregnancy be avoided.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10484192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits prostaglandin synthesis by decreasing the activity of the enzyme, cyclooxygenase, which results in decreased formation of prostaglandin precursors",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F10484195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/51/10036?source=see_link\">",
"      see \"Diclofenac (ophthalmic): Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not use hydrogel soft contact lenses during ophthalmic diclofenac therapy.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15967 Version 23.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-1A66C01F0E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32787=[""].join("\n");
var outline_f32_1_32787=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8016890\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8016891\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10484186\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10484193\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8017237\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8016893\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10484194\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10484191\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10484187\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8016888\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8016903\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10484188\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10484189\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15117524\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299184\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9811041\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8017290\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8017291\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10484192\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10484195\">",
"      Patient Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15967\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15967|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?14/63/15348?source=related_link\">",
"      Diclofenac (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/51/10036?source=related_link\">",
"      Diclofenac (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?8/43/8890?source=related_link\">",
"      Diclofenac (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?20/32/20998?source=related_link\">",
"      Diclofenac (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/52/31560?source=related_link\">",
"      Diclofenac (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?24/21/24920?source=related_link\">",
"      Diclofenac (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/29/2518?source=related_link\">",
"      Diclofenac (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?1/43/1720?source=related_link\">",
"      Diclofenac (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_1_32788="Nateglinide: Patient drug information";
var content_f32_1_32788=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Nateglinide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/21/11606?source=see_link\">",
"     see \"Nateglinide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F200158\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Starlix&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F200159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Starlix&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018771\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691404",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower blood sugar in patients with high blood sugar (diabetes).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702578",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to nateglinide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Acidic blood problem or type 1 diabetes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697009",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are 80 or older, use this drug with care. You could be more sensitive to low blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698422",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check your blood sugar as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698495",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam and visit the foot doctor every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696750",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not drive if your blood sugar has been low. There is a greater chance of you having a crash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698210",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood sugar may occur. Signs may be dizziness, headache, feeling sleepy, feeling weak, shaking, a fast heartbeat, confusion, hunger, or sweating. Keep hard candies, glucose tablets, liquid glucose, or juice on hand for low blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating. Mild pain drugs may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very low blood sugar or very high blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695966",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be used alone or with other high blood sugar (diabetes) drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 1 to 30 minutes before meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695103",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If a meal is skipped, skip the dose. If a meal is added, add a dose for that meal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it, with a meal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10894 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-27.109.116.13-0D0D3C1A28-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32788=[""].join("\n");
var outline_f32_1_32788=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200158\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200159\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018771\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018770\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018775\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018776\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018778\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018773\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018774\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018779\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018780\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?11/21/11606?source=related_link\">",
"      Nateglinide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_1_32789="Zidovudine and lamivudine: Patient drug information";
var content_f32_1_32789=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Zidovudine and lamivudine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/56/901?source=see_link\">",
"     see \"Zidovudine and lamivudine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?18/61/19413?source=see_link\">",
"     see \"Zidovudine and lamivudine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F235239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Combivir&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F235240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Combivir&reg;;",
"     </li>",
"     <li>",
"      Teva-Lamivudine/Zidovudine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700756",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause unsafe changes in blood cell count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700716",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause liver problems and a change in acid levels in the blood. Closely read the part in this leaflet which lists when to call your doctor. Pregnancy, obesity, and/or longer therapy may raise this chance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700737",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause muscle aches and stiffness if it is used for long periods of time. Closely read the part in this leaflet which lists when to call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat HIV infection.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022181\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703144",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to zidovudine, lamivudine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697801",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may not be alert. Avoid driving and doing other tasks or actions until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If this drug changes for HIV infection, make sure to ask your doctor about hepatitis B care.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To protect from diseases caused by having sex, use a latex condom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697729",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy in HIV disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696711",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not breast-feed if you have HIV disease unless your doctor tells you to.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritated pancreas may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain, back pain, soreness, or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695216",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In HIV care, this drug is most often taken with 2 other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose, brand, or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11438 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-629A639819-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32789=[""].join("\n");
var outline_f32_1_32789=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235239\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235240\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022180\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022182\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022181\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022186\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022187\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022189\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022184\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022185\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022190\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022191\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?0/56/901?source=related_link\">",
"      Zidovudine and lamivudine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?18/61/19413?source=related_link\">",
"      Zidovudine and lamivudine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_1_32790="Etanercept: Pediatric drug information";
var content_f32_1_32790=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Etanercept: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"    see \"Etanercept: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/34/36389?source=see_link\">",
"    see \"Etanercept: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F6655343\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F167887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Enbrel&reg;;",
"     </li>",
"     <li>",
"      Enbrel&reg; SureClick&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F167888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Enbrel&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1047265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antirheumatic, Disease Modifying",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Tumor Necrosis Factor (TNF) Blocking Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1047258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"      see \"Etanercept: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Juvenile idiopathic arthritis:",
"     </b>",
"     Children and Adolescents 2-17 years: 0.8 mg/kg/dose once weekly; maximum dose: 50 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Alternative twice-weekly dosing: 0.4 mg/kg/dose twice weekly given 72-96 hours apart; maximum dose: 25 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Plaque psoriasis:",
"     </b>",
"     Children and Adolescents 4-17 years: 0.8 mg/kg/dose once weekly; maximum dose: 50 mg (Hawroot, 2006; Paller,  2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Once-weekly dosing: 50 mg once weekly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Twice weekly dosing: 25 mg given twice weekly (individual doses should be separated by 72-96 hours); maximum amount administered at a single injection site: 25 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Plaque psoriasis:",
"     </b>",
"     Initial: 50 mg twice weekly (administered 72-96 hours apart) for 3 months;",
"     <b>",
"      Note:",
"     </b>",
"     Initial doses of 25 mg or 50 mg per week were also shown to be efficacious; maintenance dose: 50 mg once weekly",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F167868\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Enbrel&reg;: 25 mg [contains benzyl alcohol (in diluent), sucrose 10 mg; derived from or manufactured using Chinese hamster ovary cells]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Enbrel&reg;: 50 mg/mL (0.51 mL, 0.98 mL) [contains natural rubber/natural latex in packaging, sucrose 1%; derived from or manufactured using Chinese hamster ovary cells; prefilled syringe]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Enbrel&reg; SureClick&reg;: 50 mg/mL (0.98 mL) [contains natural rubber/natural latex in packaging, sucrose 1%; derived from or manufactured using Chinese hamster ovary cells; autoinjector]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F167854\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088590.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088590.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1047268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multiple-use vial: To avoid foaming, add 1 mL of bacteriostatic water for injection slowly to 25 mg vial, resulting in 25 mg/mL solution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Single-use prefilled syringe or prefilled SureClick autoinjector: Allow injection to reach room temperature (do not remove needle cover or needle shield during this period). Administer by SubQ injection into thigh, abdomen, or upper arm; injection sites should be rotated with subsequent doses given at least 1 inch from an old site; do not inject into areas where the skin is tender, bruised, red, or hard. Do not administer &gt;25 mg at a single injection site if the multiple-use vial is used to prepare the dose.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1047261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store vial, single-use prefilled syringe, and prefilled SureClick autoinjector in the refrigerator 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); do not freeze; protect from light.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Store multiple-use vial in the refrigerator 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); do not freeze; reconstituted solution prepared with bacteriostatic water for injection is stable for 14 days if refrigerated; do not shake or agitate vigorously; do not use if discolored or cloudy or if particulate matter is present; do not filter reconstituted solution; do not add or mix with other medications",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1047267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of moderately- to severely-active polyarticular juvenile idiopathic arthritis (FDA approved in ages &ge;2 years). Treatment of signs and symptoms of moderately- to severely-active rheumatoid arthritis; psoriatic arthritis; and active ankylosing spondylitis (FDA approved in ages &ge;18 years); treatment of chronic (moderate-to-severe) plaque psoriasis in patients who are candidates for systemic therapy or phototherapy (FDA approved in ages &ge;18 years)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F7914269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Enbrel&reg; may be confused with Levbid&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F167917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, fever, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain (more common in children), diarrhea, dyspepsia, nausea, vomiting (more common in children)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reaction (bleeding, bruising, erythema, itching, pain, or swelling)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Cough, pharyngitis, respiratory disorder, respiratory tract infection, rhinitis, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Infection (more common in adults), positive ANA, positive antidouble-stranded DNA antibodies",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Abscess, adenopathy, allergic reactions, anemia, angioedema, anorexia, aplastic anemia, appendicitis, aseptic meningitis, aspergillosis, bursitis, cerebral ischemia, cholecystitis, coagulopathy, cutaneous ulcer, deep vein thrombosis, demyelinating CNS disorders (suggestive of multiple sclerosis, transverse myelitis, or optic neuritis), depression, erythema multiforme, esophagitis, gastritis, gastroenteritis, gastrointestinal hemorrhage, heart failure, hepatitis (autoimmune), herpes zoster, hydrocephalus (with normal pressure), hyper-/hypotension, hypersensitivity, inflammatory bowel disease, interstitial lung disease, intestinal perforation, leukemias, leukopenia, lupus erythematous (cutaneous), lupus-like syndrome, lymphadenopathy, lymphomas, malignancies, melanoma, membranous glomerulopathy, Merkel cell carcinoma, MI, mouth ulcer, multiple sclerosis, myocardial ischemia, neutropenia, nonmelanoma skin cancer, optic neuritis, pancreatitis, pancytopenia,",
"     <i>",
"      Pneumocystis jiroveci",
"     </i>",
"     pneumonia, polymyositis, psoriasis (including new onset, palmoplantar, pustular, or exacerbation), pulmonary disease, pulmonary embolism, renal calculus, sarcoidosis, scleritis, seizure, stroke, Stevens-Johnson syndrome, subcutaneous nodules, thrombocytopenia, thrombophlebitis, toxic epidermal necrolysis, tuberculosis, tuberculous arthritis, urinary tract infection, uveitis, varicella infection, vasculitis (cutaneous and systemic), weight gain",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1047272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to etanercept or any component (ie, mannitol, sucrose, tromethamine, and benzyl alcohol); patients with sepsis",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1047257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with a history of recurrent infections or illnesses, such as poorly controlled diabetes which predisposes the patient to infection; discontinue etanercept in a child who develops varicella infection or who has a significant exposure to varicella virus and consider prophylactic treatment with varicella-zoster immune globulin. Use with caution in patients with heart failure or decreased left ventricular function; worsening and new-onset heart failure has been reported. Use with caution in patients with a history of significant hematologic abnormalities; has been associated with pancytopenia and aplastic anemia (rare cases in postmarketing experience). Patients must be advised to seek medical attention if they develop signs and symptoms suggestive of blood dyscrasias; discontinue if significant hematologic abnormalities are confirmed.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1047256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serious and potentially fatal infections (including bacterial, mycobacterial, viral, and invasive fungal infections) have been reported with use",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Patients were frequently taking concomitant immunosuppressants or corticosteroids. Closely monitor patients for signs and symptoms of infection while undergoing and after treatment. Discontinue administration if patient develops a serious infection or sepsis. Caution should be exercised when considering the use in patients with chronic infection, history of recurrent infection, or predisposition to infection (such as poorly controlled diabetes). Do not give to patients with an active or localized infection. Tuberculosis (disseminated or extrapulmonary) has been reported in patients receiving etanercept",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; both reactivation of latent infection and new infections have been reported. Patients should be evaluated for tuberculosis risk factors and for latent tuberculosis with a tuberculin skin test prior to starting and periodically during therapy. Treatment of latent tuberculosis should be initiated before etanercept is used; consider antituberculosis treatment if adequate course of treatment cannot be confirmed in patients with a history of latent or active tuberculosis or with risk factors despite negative skin test. Some patients who tested negative prior to therapy have developed active infection; monitor for signs and symptoms of tuberculosis in all patients. Rare reactivation of hepatitis B has occurred in chronic carriers of the virus; evaluate prior to etanercept initiation and during treatment in patients at risk for hepatitis B infection. Due to higher incidence of serious infections, etanercept should not be used in combination with anakinra or abatacept. Allergic reactions may occur, if an anaphylactic reaction or other serious allergic reaction occurs, administration should be discontinued immediately and appropriate therapy initiated.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Rare cases of CNS demyelinating disorders, such as multiple sclerosis, transverse myelitis, optic neuritis, Guillain-Barr&eacute; syndrome, other peripheral demyelinating neuropathies, and seizure disorders have been reported in patients undergoing etanercept therapy; cases may present with mental status changes and some may be associated with permanent disability.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     In children and adolescents, lymphomas and other malignancies, some fatal, have been reported with use of TNF blockers",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Use may affect defenses against malignancies; impact on the development and course of malignancies is not fully defined. In an analysis of children and adolescents who had received TNF blockers (etanercept and infliximab), the FDA identified 48 cases of malignancy. Of the 48 cases, ~50% were lymphomas (eg, Hodgkin&rsquo;s and non-Hodgkin&rsquo;s lymphoma). Other malignancies, such as leukemia, melanoma, and solid organ tumors, were reported; malignancies rarely seen in children (eg, leiomyosarcoma, hepatic malignancies, and renal cell carcinoma) were also observed. Of note, most of these cases (88%) were receiving other immunosuppressive medications (eg, azathioprine and methotrexate). As compared to the general population, an increased risk of lymphoma has been noted in clinical trials; however, rheumatoid arthritis has been previously associated with an increased rate of lymphoma. The role of TNF blockers in the development of malignancies in children cannot be excluded. The FDA also reviewed 147 postmarketing reports of leukemia (including acute myeloid leukemia, chronic lymphocytic leukemia, and chronic myeloid leukemia) in patients (children and adults) using TNF blockers. Average onset time to development of leukemia was within the first 1-2 years of TNF blocker initiation. Although most patients were receiving other immunosuppressive agents, the role of TNF blockers in the development of leukemia could not be excluded. The FDA concluded that there is a possible association with the development of leukemia and the use of TNF blockers. Patients should be monitored closely for signs and symptoms suggestive of malignancy, evidence of which should result in prompt discontinuation of the medication and appropriate diagnostic evaluation.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Long-term carcinogenic potential or effect on fertility are unknown. Use is not recommended in patients with Wegener's granulomatosis receiving immunosuppressive therapy due to higher incidence of noncutaneous solid malignancies. Positive antinuclear antibody titers have been detected in patients (with negative baselines). Rare cases of autoimmune disorders, including lupus-like syndrome or autoimmune hepatitis, have been reported; monitor and discontinue if symptoms develop. Use with caution in patients with moderate to severe alcoholic hepatitis.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Diluent for etanercept injection contains benzyl alcohol which may cause allergic reactions in susceptible individuals; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; avoid use of etanercept products containing benzyl alcohol in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate, a metabolite of benzyl alcohol, displaces bilirubin from protein binding sites; patients with latex allergy should not handle the needle cap on the prefilled syringe and on the SureClick autoinjector since it contains latex.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F167863\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abatacept: Anti-TNF Agents may enhance the adverse/toxic effect of Abatacept. An increased risk of serious infection during concomitant use has been reported.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anakinra: Anti-TNF Agents may enhance the adverse/toxic effect of Anakinra. An increased risk of serious infection during concomitant use has been reported.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: Etanercept may enhance the adverse/toxic effect of Belimumab.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Canakinumab: Anti-TNF Agents may enhance the adverse/toxic effect of Canakinumab. Specifically, the risk for serious infections and/or neutropenia may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Certolizumab Pegol: Anti-TNF Agents may enhance the immunosuppressive effect of Certolizumab Pegol.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyclophosphamide: Etanercept may enhance the adverse/toxic effect of Cyclophosphamide. An increased risk of solid cancer development may be present.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rilonacept: Anti-TNF Agents may enhance the adverse/toxic effect of Rilonacept.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May enhance the immunosuppressive effect of Anti-TNF Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Anti-TNF Agents may enhance the adverse/toxic effect of Tofacitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F167865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F167876\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Developmental toxicity studies performed in animals have revealed no evidence of harm to the fetus. There are no studies in pregnant women; this drug should be used during pregnancy only if clearly needed. A pregnancy registry has been established to monitor outcomes of women exposed to etanercept during pregnancy (877-311-8972).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1047264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Assess for joint swelling, pain, and tenderness; ESR or C-reactive protein level; CBC with differential and platelet count; tuberculin skin test; signs and symptoms of infection; screen for hepatitis B in high risk patients",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1047255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Binds to tumor necrosis factor (TNF) and blocks its interaction with cell surface TNF receptors rendering TNF biologically inactive; modulates biological responses that are induced or regulated by TNF",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1047270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: RA: 1-2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: RA: Full effect is usually seen within 3 months",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1047271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Absorbed slowly after SubQ injection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 1.78-3.39 L/m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: SubQ: 60%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 70-94.8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 102 &plusmn; 30 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: SubQ: 69 &plusmn; 34  hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Clearance:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 4-17 years: 46 mL/hour/m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 160 &plusmn; 80 mL/hour",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1047263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/34/36389?source=see_link\">",
"      see \"Etanercept: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Read the Medication Guide that you receive with this prescription and ask questions prior to therapy initiation. If redness, swelling, or irritation appears at the injection site, contact physician. Do not have any vaccinations while using this medication without consulting prescriber first.  May experience headache or dizziness (use caution when driving or engaging in tasks requiring alertness until response to drug is known). If stomach pain or cramping; unusual bleeding or bruising; difficulty breathing; persistent fever; paleness; blood in vomitus, stool, or urine occurs, stop medication and contact prescriber",
"     <b>",
"      immediately",
"     </b>",
"     . Also immediately report skin rash, unusual muscle or bone weakness, or signs of respiratory flu or other infection (eg, chills, fever, sore throat, easy bruising or bleeding, mouth sores, unhealed sores).",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F13227736\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prefilled syringe (25 mg and 50 mg) and SureClick autoinjector (50 mg) contains 1% sucrose, 100 mM NaCl, 25 mM of L-arginine, and 25 mM of sodium phosphate",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Hawrot AC, Metry DW, Theos AJ, et al, \"Etanercept for Psoriasis in the Pediatric Population: Experience in Nine Patients,\"",
"      <i>",
"       Pediatr Dermatol",
"      </i>",
"      , 2006, 23(1):67-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/1/32790/abstract-text/16445417/pubmed\" id=\"16445417\" target=\"_blank\">",
"        16445417",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ilowite NT, &ldquo;Current Treatment of Juvenile Rheumatoid Arthritis,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2002, 109(1):109-15.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/1/32790/abstract-text/11773549/pubmed\" id=\"11773549\" target=\"_blank\">",
"        11773549",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lovell DJ, Reiff A, Jones OY, et al, \"Long-Term Safety and Efficacy of Etanercept in Children With Polyarticular-Course Juvenile Rheumatoid Arthritis,\"",
"      <i>",
"       Arthritis Rheum",
"      </i>",
"      , 2006, 54(6):1987-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/1/32790/abstract-text/16732547/pubmed\" id=\"16732547\" target=\"_blank\">",
"        16732547",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moreland LW, Baumgartner SW, Schiff MH, et al, &ldquo;Treatment of Rheumatoid Arthritis With a Recombinant Human Tumor Necrosis Factor Receptor (p75)-Fc Fusion Protein,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1997, 337(3):141-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/1/32790/abstract-text/9219699/pubmed\" id=\"9219699\" target=\"_blank\">",
"        9219699",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Paller AS, Siegfried EC, Langley RG, et al, \"Etanercept Treatment for Children and Adolescents With Plaque Psoriasis,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2008, 358(3):241-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/1/32790/abstract-text/18199863/pubmed\" id=\"18199863\" target=\"_blank\">",
"        18199863",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13284 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-27.109.116.13-83254367CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32790=[""].join("\n");
var outline_f32_1_32790=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6655343\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167887\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167888\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047265\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047258\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167868\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167854\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874648\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047268\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047261\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047267\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7914269\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167917\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047272\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047257\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047256\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299288\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167863\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167865\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167876\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047264\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047255\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047270\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047271\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047263\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13227736\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13284\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13284|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=related_link\">",
"      Etanercept: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/34/36389?source=related_link\">",
"      Etanercept: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_1_32791="Modified Epleys Left";
var content_f32_1_32791=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F50861&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F50861&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 530px\">",
"   <div class=\"ttl\">",
"    Modified Epley's maneuver for self-treatment of benign positional vertigo (left)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 510px; height: 435px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This maneuver should be carried out three times a day. Repeat this daily until you are free from positional vertigo for 24 hours.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from Http://www.charite.de/ch/neuro/englishL.htm",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32791=[""].join("\n");
var outline_f32_1_32791=null;
var title_f32_1_32792="Height velocity in boys";
var content_f32_1_32792=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66909%7EPEDS%2F74573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66909%7EPEDS%2F74573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 566px\">",
"   <div class=\"ttl\">",
"    Height velocity in American boys",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 546px; height: 700px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Height velocity by age for American boys. Red line: 50th centile for boys maturing 2 SD earlier than the mean; Green line: 50th centile for boys maturing 2 SD later than the mean. Other lines show the 3rd (purple) through 97th (blue) centiles for boys maturing at an average time.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tanner JM, Davies S. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985; 107:317. Copyright &copy; 1985 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 566px\">",
"   <div class=\"ttl\">",
"    Height velocity in American girls",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 546px; height: 700px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Height velocity by age for American girls. Purple line: 50th centile for girls maturing 2 SD earlier than the mean; Yellow line: 50th centile for girls maturing 2 SD later than the mean. Other lines show the 3rd (red) through 97th (blue) centiles for girls maturing at an average time.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tanner JM, Davies S. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985; 107:317. Copyright &copy; 1985 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32792=[""].join("\n");
var outline_f32_1_32792=null;
var title_f32_1_32793="Epidermolysis bullosa acquisita";
var content_f32_1_32793=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62505%7EDERM%2F83259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62505%7EDERM%2F83259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Epidermolysis bullosa acquisita",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tense bullae, erosions, and crusts on skin of patient with epidermolysis bullosa acquisita.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Epidermolysis bullosa acquisita",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32793=[""].join("\n");
var outline_f32_1_32793=null;
var title_f32_1_32794="Principles of medication use during lactation";
var content_f32_1_32794=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"8\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Principles of medication use during lactation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/1/32794/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/1/32794/contributors\">",
"     Alison Stuebe, MD, MSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/1/32794/contributors\">",
"     Karen Fiumara, PharmD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/1/32794/contributors\">",
"     Kimberly G Lee, MD, MS, IBCLC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/1/32794/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/1/32794/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/1/32794/contributors\">",
"     Kathleen J Motil, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/1/32794/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/1/32794/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/1/32794/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breastfeeding is the preferred form of infant nutrition during the first six months of life. Both the American Academy of Pediatrics (AAP) and the World Health Organization (WHO) recommend that children continue to breastfeed until at least one or two years of age, and thereafter as long as mutually desired [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. For these reasons, physicians from all medical specialties are likely to care for women who are breastfeeding; thus, they should be familiar with the principles of medication use in nursing mothers.",
"   </p>",
"   <p>",
"    Women depend upon their physicians to provide accurate information on whether a medication passes into breast milk and, if it does pass into the milk, to provide information on the potential risks of exposing their children to the medication, as well as the risks of not breastfeeding. Without such information, patients and physicians alike sometimes make ill-advised decisions to refrain from initiating breastfeeding or to wean, despite the fact that the vast majority of medications are safe for nursing mothers and their children.",
"   </p>",
"   <p>",
"    The importance of providing accurate information is illustrated in the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, hyperthyroid women taking",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/9/5271?source=see_link\">",
"       propylthiouracil",
"      </a>",
"      (PTU) were significantly less likely to breastfeed than those who did not require PTU (44 versus 83 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/3\">",
"       3",
"      </a>",
"      ], despite the fact that the American Academy of Pediatrics (AAP) lists PTU as a drug that is \"compatible with breastfeeding.\" Among patients who were taking PTU, the only significant predictor of the decision to breastfeed was physician advice. A concurrent survey of endocrinologists and family practitioners in the study catchment area showed that 44 percent of endocrinologists and 27 percent of family practitioners would counsel a woman not to breastfeed if she were taking PTU. This suggests that the lower rate of breastfeeding among women taking PTU may have been related, at least in part, to their physician's lack of awareness of AAP recommendations.",
"     </li>",
"     <li>",
"      A cohort study of 34 women taking antiepileptic medications found they were significantly less likely to breastfeed than matched controls not taking medication (50 versus 85 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/4\">",
"       4",
"      </a>",
"      ]. Women choosing not to breastfeed most frequently cited maternal medication or maternal illness as their primary reason. They were also more likely to have been advised by their physicians not to breastfeed, although the AAP deems many anticonvulsants compatible with breastfeeding.",
"     </li>",
"     <li>",
"      Another study attempted to determine the reliability of safety recommendations for drugs used during lactation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/5\">",
"       5",
"      </a>",
"      ]. The authors obtained information on safety during breastfeeding of 14 commonly used medications and compared this information with that from the best available current research and information sources. They found that the reliability of lactation safety information, especially in major retail pharmacy databases, was not always accurate. In fact, two retail pharmacy databases frequently gave an alternative recommendation for drugs believed to be unequivocally safe. This may result in many women being inappropriately advised to stop breastfeeding.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Furthermore, accurate information alone, without additional counseling and reassurance by the patient's physician, may not be enough to ensure continued breastfeeding. Another study recontacted 203 women who had called the Motherisk program for information about safety of antibiotics during lactation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/6\">",
"     6",
"    </a>",
"    ]. All of the women had received reassuring advice about medication safety; however, 19 of 125 women subsequently contacted had not complied with their treatment, and another seven weaned their infants at the time of therapy. These data suggest that physicians should both provide information on medication safety and encourage continued nursing to avoid unnecessary early weaning or maternal non-compliance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARMACODYNAMICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Factors that affect the transfer of medications into human milk include timing of the dose with respect to breastfeeding, bioavailability, and maternal clearance. In general, drugs that are most likely to be transferred from maternal plasma to milk have the following characteristics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nonionized",
"     </li>",
"     <li>",
"      Nonprotein bound",
"     </li>",
"     <li>",
"      Low molecular weight",
"     </li>",
"     <li>",
"      High lipid solubility",
"     </li>",
"     <li>",
"      Weak bases",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The molecular mechanisms by which drugs and other chemicals are transferred into breast milk are not well defined. A study in mice showed that the breast cancer resistance protein (encoded by ABCG2) was highly expressed in mouse mammary gland epithelium in late pregnancy and during lactation, but not at other times [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/9\">",
"     9",
"    </a>",
"    ]. This protein is a transmembrane",
"    <span class=\"nowrap\">",
"     drug/toxin",
"    </span>",
"    transporter and appeared to enhance transfer of certain drugs and toxins from plasma to milk, an effect that could be inhibited by administration of an ABCG2 inhibitor.",
"   </p>",
"   <p>",
"    Milk is approximately 0.2 pH units lower than plasma; therefore, drugs with high pH (weak bases) will be ionized in the more acidic milk environment and will be concentrated in the milk (eg, beta-blockers). Weak acids are more concentrated in maternal plasma than in milk (eg, penicillins). However, a long half-life for elimination will overcome ionization and protein binding because ionized and protein bound compounds are in an equilibrium with their nonionized and nonprotein forms (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Transfer of drugs also changes during the early postpartum period. In the first few days of lactogenesis, immature tight junctions allow paracellular transport of drugs into colostrum. Once these tight junctions mature, usually within 72 hours postpartum, higher molecular weight compounds are less able to pass into the milk compartment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/7\">",
"     7",
"    </a>",
"    ]. While this phenomenon may increase the transfer of drug into milk in the early postpartum period, the volume of colostrum is low, so the total amount of drug the infant consumes is similar to that observed with mature milk.",
"   </p>",
"   <p>",
"    The amount of drug transferred from plasma to milk is expressed as the",
"    <span class=\"nowrap\">",
"     \"milk/plasma",
"    </span>",
"    <span class=\"nowrap\">",
"     (M/P)",
"    </span>",
"    ratio.\" This ratio will vary considerably over a dosing interval, and is best reported as a",
"    <span class=\"nowrap\">",
"     M/P",
"    </span>",
"    AUC (the area under the curve of drug concentration in both the plasma and milk) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/7,8,10\">",
"     7,8,10",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     M/P",
"    </span>",
"    point ratio (the ratio of drug concentration in milk to drug concentration in maternal plasma at a single point during a dosing interval) is less accurate as it could potentially overestimate or underestimate the actual transfer into milk depending upon the timing of the sample. However, even an appropriately obtained",
"    <span class=\"nowrap\">",
"     milk/plasma",
"    </span>",
"    ratio can often be of little clinical utility due to differences in bioavailability and clearance of drugs among infants.",
"   </p>",
"   <p>",
"    A more clinically useful estimate is the \"relative infant dose\", which is the maximum percentage of the maternal dose, in milligrams per kilogram, received by the infant during a 24-hour period. By convention, a relative infant dose of less than 10 percent is considered to be safe. While the relative infant dose reflects the quantity of drug ingested, it does not account for the pharmacodynamics of the drug in the infant. Hence the convention that a relative infant dose of less than 10 percent is \"safe\" should be applied with caution to preterm or sick infants (or for psychotropic agents). Data on the",
"    <span class=\"nowrap\">",
"     milk/plasma",
"    </span>",
"    ratio and relative infant dose for maternal medications are derived from pharmacokinetic studies and published in books on medication use during lactation.",
"   </p>",
"   <p>",
"    Drug bioavailability and drug clearance in the setting of a neonate's immature renal and hepatic function determine whether a drug",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    its metabolites reach therapeutic or toxic levels. The exposure index, calculated as the",
"    <span class=\"nowrap\">",
"     M/P",
"    </span>",
"    <span class=\"nowrap\">",
"     ratio/infant",
"    </span>",
"    clearance, reflects the importance of infant metabolism in determining level of drug exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/11\">",
"     11",
"    </a>",
"    ]. A drug with a high",
"    <span class=\"nowrap\">",
"     M/P",
"    </span>",
"    ratio but rapid infant clearance may result in minimal exposure, while a drug with a low",
"    <span class=\"nowrap\">",
"     M/P",
"    </span>",
"    ratio and slow infant clearance may accumulate and cause side-effects.",
"   </p>",
"   <p>",
"    Infant metabolism becomes especially important when advising mothers of premature infants and neonates, who may have markedly reduced rates of drug metabolism. As an example, the half-life of caffeine in a neonate is more than 90 hours, compared with 2.6 hours in a six month old infant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/12\">",
"     12",
"    </a>",
"    ]. Infant clearance is estimated to be 5, 10, 33, 66 and 100 percent of adult levels at 24 to 28, 34 to 40, 40 to 44, 44 to 68, and &gt;68 weeks post-conception, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, the blood brain barrier in neonates is immature; in fact, it is not fully developed until the middle of the first year of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/14\">",
"     14",
"    </a>",
"    ]. Thus, there is a higher potential for central nervous system (CNS) toxicity from drug ingestion in neonates. Moreover, since drugs directed at the CNS (eg, psychotropic medications) are lipophilic, they will be more highly concentrated in breast milk. Studies that only measure the concentration of drugs in breast milk without looking at possible CNS gradient effects run the risk of over- or underestimating neonatal effects.",
"   </p>",
"   <p>",
"    For all of these reasons, when adverse reactions in nursing infants occur, they most often happen in the neonatal period (first four weeks after birth) and nearly all occur in the first six months of life. Adverse reactions after six months of age are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Maternal drug metabolism may also influence infant dose. It is always important to be alert to an infant's manifestation of side effects of maternal medications, even those usually considered safe. In addition, the clinician should be alert to maternal side effects as these may be an indication that the mother has a higher than normal serum drug concentration. As an example, an ultra-rapid CYP2D6 metabolizer given a low dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    for two weeks was noted to have very high levels of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    (the metabolic product of codeine) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/16\">",
"     16",
"    </a>",
"    ], which were transferred into her milk and affected her infant (see",
"    <a class=\"local\" href=\"#H21\">",
"     'Analgesics'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DRUG EFFECTS ON MILK SUPPLY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some maternal medications and habits affect the initiation and maintenance of lactogenesis. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Increase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dopamine antagonists, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    , increase prolactin levels and have been used off-label to augment milk supply or induce lactation in adoptive mothers. Several case series have reported use of metoclopramide (10 or 15 mg three times per day) in women with no or inadequate milk production. Metoclopramide significantly increased milk supply and decreased the need for supplementary feeds [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/17-23\">",
"     17-23",
"    </a>",
"    ]. The mechanism appears to be stimulation of prolactin secretion. A randomized trial of routine metoclopramide use by mothers of premature infants found that metoclopramide did not increase milk supply compared to placebo, but not limiting use to mothers with low milk supply may have influenced the findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/24\">",
"     24",
"    </a>",
"    ]. No randomized controlled trials have assessed the efficacy of metoclopramide in women with low milk supply. The AAP lists metoclopramide as a drug \"whose effect on nursing infants is unknown, but may be of concern\" because of its potential central nervous system effects (eg, extrapyramidal reactions) as a dopaminergic blocking agent. Nevertheless, metoclopramide is used cautiously in infants for treatment of reflux.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/43/1717?source=see_link\">",
"     Domperidone",
"    </a>",
"    , a dopamine antagonist without the central nervous system side effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    , has also been shown to improve milk supply, although this is also an off-label use of the drug. A randomized trial of domperidone use by mothers of premature infants found that domperidone increased milk production significantly more than placebo (46 versus 16 percent increase) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/25\">",
"     25",
"    </a>",
"    ]. The Unites States Food and Drug Administration (FDA) has advised against use of domperidone to increase milk production because it has been associated with development of fatal cardiac arrhythmias in individuals administered high intravenous doses of the drug. No cardiac complications have been reported in nursing mothers taking oral doses of domperidone or in infants exposed to domperidone in breast milk. A nested case control study reported an increased risk of serious ventricular arrhythmia or sudden cardiac death for oral domperidone exposure compared to proton pump inhibitor exposure (OR 1.44, 95% CI 1.12-1.86) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/26\">",
"     26",
"    </a>",
"    ]. However, in subgroup analysis, this association was not statistically significant for individuals younger than 60 (OR 1.23, 95% CI 0.32-4.76). The FDA has not approved the use of domperidone for any indication in the United States.",
"   </p>",
"   <p>",
"    The herb fenugreek has also been used as a galactogogue, and preliminary reports suggest that it may be effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/27-30\">",
"     27-30",
"    </a>",
"    ]. Side effects include a maple-syrup odor, diarrhea, low blood glucose or potassium, impaired hemostasis, and increased asthmatic symptoms. Fenugreek has been taken as a tea or in capsule form. Information on relative bioavailability and potency is not available for herbal preparations.",
"   </p>",
"   <p>",
"    Galactagogues should never be used in the place of an evaluation and correction of any modifiable factors such as frequency and thoroughness of breast emptying. These agents should be used with caution and mothers need to be aware of the lack of data supporting their use. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/15/17658?source=see_link&amp;anchor=H115298558#H115298558\">",
"     \"Common problems of breastfeeding and weaning\", section on 'Galactagogues'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Decrease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dopamine agonists (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    ) decrease prolactin release from the pituitary and inhibit milk production.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/40/8840?source=see_link\">",
"     Bromocriptine",
"    </a>",
"    had been used to inhibit postpartum breast engorgement, but is no longer used for this purpose because it has been associated with severe adverse reactions, including maternal intracranial hemorrhage, puerperal psychosis and myocardial infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/31\">",
"     31",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/2/7206?source=see_link\">",
"     Cabergoline",
"    </a>",
"    , a newer dopamine agonist, has been used successfully off-label to inhibit lactation in the postpartum period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. The most common side effects are nausea, vomiting, headache and dizziness. Although severe adverse reactions have not been reported for cabergoline, published studies were not powered to detect rare but severe adverse effects. Moreover, there is only weak evidence that dopamine agonists are better than no pharmacologic treatment for suppression of lactation symptoms in the first week postpartum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Given the potential risks and lack of medical benefit, use of drugs to inhibit milk production postpartum is not recommended. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/15/17658?source=see_link&amp;anchor=H24#H24\">",
"     \"Common problems of breastfeeding and weaning\", section on 'Weaning'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Estrogen in high doses suppresses lactation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/34\">",
"     34",
"    </a>",
"    ]. Although estrogen-progestin contraception is believed to impair lactation, the available evidence from randomized trials is limited and of poor quality. A systematic review of these trials concluded that there were insufficient data to determine whether estrogen-progestin contraceptives affect milk supply [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/8/24713?source=see_link&amp;anchor=H14#H14\">",
"     \"Postpartum and postabortion contraception\", section on 'Estrogen-progestin contraceptives'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although falling progesterone levels trigger lactogenesis, progestin-only contraceptives do not appear to decrease milk production. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/8/24713?source=see_link&amp;anchor=H13#H13\">",
"     \"Postpartum and postabortion contraception\", section on 'Progestin only methods'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Intense diuresis induced by a diuretic can decrease milk supply [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antihistamines in relatively high doses can decrease basal serum prolactin in early postpartum women, but suckling-induced prolactin secretion does not appear to be affected and the effect on milk supply has not been studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19190?source=see_link\">",
"     Pseudoephedrine",
"    </a>",
"    inhibits milk production (see",
"    <a class=\"local\" href=\"#H19\">",
"     'Nasal decongestants'",
"    </a>",
"    below); other pharmacologically similar vasoconstrictors may have a similar effect on milk supply.",
"   </p>",
"   <p>",
"    Moderate to heavy alcohol consumption and cigarette smoking are both known to decrease milk production",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    length of nursing. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Social substances'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The FDA does not require drug companies to conduct studies on medication use in lactation, and drug monographs published in the Physicians Desk Reference may not include information on the AAP rating (see",
"    <a class=\"local\" href=\"#H396539584\">",
"     'American Academy of Pediatrics'",
"    </a>",
"    below) for a particular medication. In addition, drug monographs may not reflect data accrued following FDA approval of the medication.",
"   </p>",
"   <p>",
"    For new medications for which limited data are available, a MEDLINE search using the search terms: \"milk, human,\" \"lactation,\" \"breastfeeding,\" and combining with the medication in question should yield all published primary data. Also, there are several information centers which collect data on medication safety and may be able to provide the most up to date information (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Other resources'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Data on medication safety in breastfeeding are frequently limited to case reports of adverse infant outcomes associated with maternal use of a medication. When pharmacodynamic data exist, they are often acquired from small series of mother-infant dyads. The best data include long-term infant outcomes after drug exposure; however, since such information is only rarely available, most safety recommendations reflect expert opinion rather than evidence-based information.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H396539577\">",
"    <span class=\"h2\">",
"     LactMed",
"    </span>",
"    &nbsp;&mdash;&nbsp;The LactMed database, produced by the National Library of Medicine, provides monographs on many prescription and over-the-counter medications. The database is available free of charge through the internet (",
"    <a class=\"external\" href=\"file://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT\">",
"     file://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT",
"    </a>",
"    ). One study showed that LactMed consistently had more comprehensive and current references for its reviews than other commonly-used information sources [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/5\">",
"     5",
"    </a>",
"    ]. Based on these findings, we suggest using LactMed for information on drug safety in lactation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H396539584\">",
"    <span class=\"h2\">",
"     American Academy of Pediatrics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AAP provides information on several hundred commonly prescribed medications, as well as other agents that may pass into breast milk. They are classified into several categories:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cytotoxic drugs",
"     </li>",
"     <li>",
"      Drugs of abuse with adverse effects",
"     </li>",
"     <li>",
"      Radioactive compounds",
"     </li>",
"     <li>",
"      Drugs whose effects are unknown, but \"may be of concern\"",
"     </li>",
"     <li>",
"      Drugs which should be used \"with caution\"",
"     </li>",
"     <li>",
"      Drugs which are generally \"compatible with breastfeeding\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The AAP periodically revises its list of agents transferred into human milk and describes the possible effects of these agents on the infant or on lactation, if known [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/38\">",
"     38",
"    </a>",
"    ]. If an agent does not appear on the list, it does not mean that it is not transferred into human milk or that it does not have an effect on the infant; it only indicates that the AAP has not reviewed that agent. The AAP last updated this information in 2001, and retired the list in May 2010; it is unclear when a new list will be issued.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H396539591\">",
"    <span class=\"h2\">",
"     Books",
"    </span>",
"    &nbsp;&mdash;&nbsp;The book Medications and Mothers' Milk by Thomas Hale is another complete and authoritative resource [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/10\">",
"     10",
"    </a>",
"    ]. It uses a five-point scale to rank information on drug safety during lactation, and includes AAP rating information, short monographs on each medication, the quality of data available, and potential concerns associated with use in lactating women. The ratings reflect not only the risks associated with medications but also the quality of information available.",
"   </p>",
"   <p>",
"    Ruth Lawrence's book, Breastfeeding: A Guide for the Medical Profession [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/39\">",
"     39",
"    </a>",
"    ], includes an appendix with detailed information on medications and lactation, including pharmacokinetic data and brief comments on the relative safety of various agents. Medications are grouped by therapeutic class to allow the clinician to select the safest drug for a given indication.",
"   </p>",
"   <p>",
"    Briggs' Drugs in Pregnancy and Lactation also includes data on medications and lactation. Drugs are listed alphabetically with citations including name, class, fetal risk summary, breast feeding summary, and references. An update, published quarterly, provides information on new drugs as soon as it is available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33601704\">",
"    <span class=\"h2\">",
"     UpToDate drug database",
"    </span>",
"    &nbsp;&mdash;&nbsp;The UpToDate drug database includes information on lactation and breastfeeding considerations for all drugs in the database. This information can be accessed by searching on the drug name, choosing the drug information topic for that drug, and clicking on the lactation and breastfeeding considerations section of the outline. Clicking on the name of any drug cited within an UpToDate topic review will also bring you to the drug information topic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other resources",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lactation Studies Center, Rochester, New York (Healthcare workers only)",
"      <br/>",
"      <br/>",
"      585 275-0088. Monday to Friday 10 AM to 3:30 PM EST",
"     </li>",
"     <li>",
"      Infant Risk Center, Texas Tech University Health Sciences Center",
"      <br/>",
"      <br/>",
"      <a class=\"external\" href=\"file://www.infantrisk.org/\">",
"       file://www.infantrisk.org/",
"      </a>",
"      <br/>",
"      <br/>",
"      806-352-2519 Monday to Friday 8am to 5pm CST",
"     </li>",
"     <li>",
"      Website produced by pediatric staff of Marina Alta's Hospital, Denia-Alicante, Spain",
"      <br/>",
"      <br/>",
"      <a class=\"external\" href=\"file://www.e-lactancia.org/ingles/inicio.asp\">",
"       file://www.e-lactancia.org/ingles/inicio.asp",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     GENERAL GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;When prescribing medication for breastfeeding women, consider the following guidelines:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Encourage women to continue to breastfeed",
"     </li>",
"     <li>",
"      Use medications with a relative infant dose of &lt;10 percent",
"     </li>",
"     <li>",
"      Use medications with a short half-life, high protein binding, low oral bioavailability and high molecular weight",
"     </li>",
"     <li>",
"      Use medications for which data are available regarding safety in infants",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pharmacodynamics in breastfeeding",
"     </li>",
"     <li>",
"      If a drug has short half-life, give it after nursing or before a prolonged period of infant sleep",
"     </li>",
"     <li>",
"      Use caution with low-birthweight or preterm infants because of potentially immature organ systems",
"     </li>",
"     <li>",
"      Collaborate with the infant's pediatrician to monitor the infant",
"     </li>",
"     <li>",
"      Discuss risks and benefits with the patient as an informed consent issue",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MEDICATIONS GENERALLY CONTRAINDICATED",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drugs that should be avoided during lactation include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Drugs with potentially harmful activity in infants",
"     </li>",
"     <li>",
"      Drugs with very high relative infant dose",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      long infant half-life",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Women requiring short courses of contraindicated medications, such as radiopharmaceuticals, may be able to express and discard milk during therapy, and then resume lactation when the contraindicated medication is no longer present (see",
"    <a class=\"local\" href=\"#H24\">",
"     'Radiopharmaceuticals'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Some specific drugs which are generally contraindicated or may be of concern include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?22/58/23466?source=see_link\">",
"       Amiodarone",
"      </a>",
"      has a long half-life and contains large amounts of iodine. It may have cardiac effects and may cause thyroid dysfunction in infants.",
"     </li>",
"     <li>",
"      <strong>",
"       Gold salts",
"      </strong>",
"      , such as aurothioglucose and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?30/47/31476?source=see_link\">",
"       auranofin",
"      </a>",
"      , have long half-lives and may be transferred into breast milk. Some experts recommend avoiding use in breastfeeding women but others, including the AAP, consider their use compatible with breastfeeding when there is no alternative.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/11/23736?source=see_link\">",
"       Lithium",
"      </a>",
"      has a relative infant dose of &le;56 percent, and infant serum concentrations may reach half of the therapeutic dose, although excretion into milk varies. Close monitoring of the infant, together with testing milk",
"      <span class=\"nowrap\">",
"       (and/or",
"      </span>",
"      infant) for lithium levels, is recommended [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/40-43\">",
"       40-43",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38745?source=see_link&amp;anchor=H22#H22\">",
"       \"Use of psychotropic medications in breastfeeding women\", section on 'Lithium'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?1/54/1897?source=see_link\">",
"       Chloramphenicol",
"      </a>",
"      is secreted into breast milk [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/44\">",
"       44",
"      </a>",
"      ], but milk concentrations are not sufficient to induce gray baby syndrome. The drug has been associated with bone-marrow suppression at therapeutic doses. Adverse reactions such as vomiting, excessive intestinal gas, and lethargy have been reported in breastfed infants of mothers taking oral chloramphenicol.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/20/23877?source=see_link\">",
"       Ergotamine",
"      </a>",
"      in breast milk may cause vomiting and diarrhea in exposed infants. The drug may also inhibit prolactin secretion and lower milk production.",
"      <br/>",
"      <br/>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32549?source=see_link\">",
"       Methylergonovine",
"      </a>",
"      is an amine ergot alkaloid used to reduce postpartum bleeding. Limited information indicates that maternal doses of methylergonovine up to 0.75 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants. Although results of several studies are mixed, it appears that methylergonovine can decrease serum prolactin and possibly the amount of milk production and duration of lactation, especially when used in the immediate postpartum period. The effect seems to be related to the dosage and route of administration, with injected doses having a greater impact than oral. A few oral doses may not severely affect lactation; however, methylergonovine should probably not be the first-line uterotonic in mothers who wish to nurse. The FDA recommends women avoid breastfeeding for at least 12 hours after receiving their last dose of methylergonovine and discard breast milk produced during this period. This recommendation was made in the absence of any available evidence of risk to breastfed infants, and has not been endorsed by other experts [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/62/1000?source=see_link\">",
"       Isotretinoin",
"      </a>",
"      and",
"      <strong>",
"       etretinate",
"      </strong>",
"      are contraindicated. Their lipid solubility makes them likely to be excreted in milk, and they are known to be mutagenic and carcinogenic in animal models.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?1/52/1862?source=see_link\">",
"       Topical tretinoin",
"      </a>",
"      is absorbed poorly from maternal skin and thus would not be expected to be transferred into breast milk or harm the infant.",
"     </li>",
"     <li>",
"      Chronic",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/49/2840?source=see_link\">",
"       tetracycline",
"      </a>",
"      use is not recommended, as it may cause staining of immature teeth. The AAP considers short-term use compatible with breastfeeding because milk levels are low and absorption by the infant is inhibited by the calcium in breast milk.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"       Doxorubicin",
"      </a>",
"      is concentrated in breast milk and may cause immune suppression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There is no information on",
"      <strong>",
"       statins",
"      </strong>",
"      . These agents probably appear in breast milk. Because of a concern with disruption of infant lipid metabolism, the consensus is that statins should not be used during breastfeeding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Additional drugs that have been associated with significant infant effects in case reports include:",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/11/37047?source=see_link\">",
"       acebutolol",
"      </a>",
"      <strong>",
"       , 5-aminosalicylic acid,",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/46/30440?source=see_link\">",
"       atenolol",
"      </a>",
"      <strong>",
"       ,",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/40/8840?source=see_link\">",
"       bromocriptine",
"      </a>",
"      <strong>",
"       , high dose",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      <strong>",
"       ,",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/62/7142?source=see_link\">",
"       clemastine",
"      </a>",
"      <strong>",
"       , phenindione,",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/40/29321?source=see_link\">",
"       phenobarbital",
"      </a>",
"      <strong>",
"       ,",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?30/14/30952?source=see_link\">",
"       primidone",
"      </a>",
"      <strong>",
"       , and",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/28/8647?source=see_link\">",
"       sulfasalazine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DRUGS BY CATEGORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A brief overview of commonly used drugs in reproductive aged women and their safety during lactation is provided below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Antimicrobials",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H396541163\">",
"    <span class=\"h3\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most antimicrobials are considered compatible with breastfeeding, with potential adverse effects in infants limited to changes in intestinal flora. Many of these drugs are used therapeutically in infants. Common antimicrobials considered compatible with breastfeeding include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Penicillins",
"     </li>",
"     <li>",
"      Cephalosporins",
"     </li>",
"     <li>",
"      Macrolides",
"     </li>",
"     <li>",
"      Aminoglycosides",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/22/25958?source=see_link\">",
"     Nitrofurantoin",
"    </a>",
"    should be avoided in breastfeeding mothers of infants under one month of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/46\">",
"     46",
"    </a>",
"    ], and in breastfeeding mothers of any infant with glucose-6-phosphate dehydrogenase (G6PD) deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/1\">",
"     1",
"    </a>",
"    ]. Before",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/59/38837?source=see_link\">",
"     primaquine",
"    </a>",
"    is given to a woman who is breastfeeding, the mother and infant should be tested for G6PD deficiency; it may be used in breastfeeding mothers and infants with normal G6PD levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of other antimicrobials is somewhat controversial:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H396541138\">",
"    <span class=\"h3\">",
"     Ofloxacin",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to LactMed, short-term use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/60/35776?source=see_link\">",
"     ofloxacin",
"    </a>",
"    is acceptable in nursing mothers and the AAP considers use of this drug compatible with breastfeeding, while others recommend against its use because it enters milk and has been associated with arthropathy in juvenile animals. Although levels of ofloxacin are similar in plasma and milk, the risk of arthropathy in nursing infants exposed to quinolones in milk is thought to be very low. A case series of 7000 children taking chronic quinolone antibiotics reported only 10 developed an arthropathy-like syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/47\">",
"     47",
"    </a>",
"    ]. However, animal studies have shown an increased risk of arthropathy in juvenile animals exposed to therapeutic doses of quinolones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H396541156\">",
"    <span class=\"h3\">",
"     Metronidazole and tinidazole",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AAP considers use of this drug, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/14/5349?source=see_link\">",
"     tinidazole",
"    </a>",
"    , of concern in nursing women. Long-term studies of risk of carcinogenesis in humans have not been performed; an association with carcinogenesis in rodents has been demonstrated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/49\">",
"     49",
"    </a>",
"    ]. A study of maternal",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    use did not show a significant increase in adverse events in the neonate compared to use of other antimicrobials, although a cohort study found a nonsignificant trend toward more loose stools and more candidal colonization in metronidazole-exposed infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/50\">",
"     50",
"    </a>",
"    ]. These data suggest that metronidazole is safe for use in lactation. Since the relative infant dose of metronidazole is high (29 percent) with maternal administration of the 2 g one-time dose, it is recommended that mothers receiving this dose express and discard their milk for 24 hours.",
"    <br/>",
"    <br/>",
"    Use of topical and vaginal metronidazole has not been studied during breastfeeding. After vaginal administration, plasma levels are less than 2 percent of those after a 500 mg oral dose, so vaginal use of metronidazole during breastfeeding is unlikely to be of concern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/51\">",
"     51",
"    </a>",
"    ]. After topical administration, blood levels are about 1 percent of the peak plasma levels after a 250 mg oral dose, so topical use is also unlikely to be of concern.",
"   </p>",
"   <p>",
"    In lactating women who are administered",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/14/5349?source=see_link\">",
"     tinidazole",
"    </a>",
"    , interruption of breastfeeding is recommended during treatment and for three days after the last dose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H408248\">",
"    <span class=\"h3\">",
"     Sulfonamides",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sulfonamides are excreted into breast milk and compete with bilirubin for binding to plasma albumin, but do not pose a significant risk for the healthy full-term neonate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. Exposure to sulfonamides via breast milk should be avoided in ill, stressed, or premature infants and in infants with hyperbilirubinemia or glucose-6-phosphate dehydrogenase deficiency because these infants are at increased risk of developing jaundice, hemolytic anemia, and, in theory, kernicterus. However, a systematic review found no cases of kernicterus associated with maternal use of sulfonamides during pregnancy or lactation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/55\">",
"     55",
"    </a>",
"    ]. LactMed concluded that it is acceptable to use sulfonamides during breastfeeding in healthy infants after the newborn period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Psychotropic medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, antianxiety medications (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    ) have not been associated with harmful effects, but the AAP considers them of concern in breastfeeding women.",
"   </p>",
"   <p>",
"    Use of psychotropic medications during lactation raises a number of issues, such as whether cumulative effects occur if the mother also took psychotropic medications during pregnancy,",
"    <span class=\"nowrap\">",
"     maternal/child",
"    </span>",
"    sequelae of untreated perinatal psychiatric illness, and lack of long-term data on outcome of exposed infants. Infants exposed during pregnancy may also experience withdrawal symptoms after delivery. The use of psychotropic medications in breastfeeding women is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38745?source=see_link\">",
"     \"Use of psychotropic medications in breastfeeding women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Antithrombotic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, and other developed countries, thromboembolic events are the leading causes of pregnancy-related mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/56\">",
"     56",
"    </a>",
"    ]. Thus, it is critical to provide safe and effective anticoagulation to patients at risk for thromboembolism during pregnancy and lactation.",
"   </p>",
"   <p>",
"    Drugs compatible with breastfeeding:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H396541202\">",
"    <span class=\"h3\">",
"     Unfractionated heparin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unfractionated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    is commonly used for thromboprophylaxis in pregnancy and is safe for use in lactation. It is a high molecular weight compound (4000 to 40,000 Daltons) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/57\">",
"     57",
"    </a>",
"    ]; its relatively large size prevents transfer into milk. Moreover, unfractionated heparin is not bioavailable through the gut mucosa, so any heparin that passes into milk is destroyed in the gastrointestinal tract of the infant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H396541231\">",
"    <span class=\"h3\">",
"     Warfarin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     Warfarin",
"    </a>",
"    is considered safe in lactation, although it is generally contraindicated during pregnancy. Warfarin is a highly polar molecule with approximately 99 percent bound to plasma proteins. Studies evaluating warfarin use in lactation indicate that warfarin is minimally secreted in milk so that infant coagulation is unaffected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/58\">",
"     58",
"    </a>",
"    ]. The AAP lists warfarin as a medication compatible with breastfeeding.",
"   </p>",
"   <p>",
"    However, limited data suggest a prolonged prothrombin time may occur in some infants, possibly due to drug interactions that could potentially alter protein binding and change the amount of free",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    in plasma. Therefore, infants should be monitored for signs and symptoms of bleeding, such as petechiae or easy bruising. Vitamin K supplementation is recommended for very premature infants, who are at increased risk of intracranial hemorrhage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H396541209\">",
"    <span class=\"h3\">",
"     Low molecular weight heparins",
"    </span>",
"    &nbsp;&mdash;&nbsp;No special precautions are required when breastfeeding women are taking these drugs. Low molecular weight heparins (LMWH), such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/56/32648?source=see_link\">",
"     dalteparin",
"    </a>",
"    , still have a relatively high molecular weight (average molecular weight of 4000 to 6500 Daltons), making it difficult for them to transfer into milk. In a study of 15 lactating mothers given 2500 units of dalteparin following cesarean delivery, transfer of LMWH into milk was observed in 11 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/59\">",
"     59",
"    </a>",
"    ]. The quantity of drug transferred was minimal and the authors concluded that clinically meaningful effects for the nursing infant were unlikely. In another study of 12 women receiving enoxaparin in the postpartum period, factor Xa levels were undetectable in their exclusively breastfed infants after five days of medication use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/60\">",
"     60",
"    </a>",
"    ]. Like unfractionated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , biologically active LMWHs are not absorbed from gut mucosa.",
"   </p>",
"   <p>",
"    The safety of other antithrombotic agents is less clear:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H396541216\">",
"    <span class=\"h3\">",
"     Antiplatelet drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/9/34969?source=see_link\">",
"     Clopidogrel",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/27/35255?source=see_link\">",
"     ticlopidine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/63/27639?source=see_link\">",
"     prasugrel",
"    </a>",
"    are antiplatelet drugs, which, like",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , irreversibly inhibit platelet activation. Thus, small quantities in milk could theoretically cause long lasting effects in a nursing infant. Unfortunately, little is known regarding the transfer of these drugs into milk. The decision to use one of these agents instead of low dose aspirin must be made on a clinical basis until there is published evidence to help guide decision-making [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/10\">",
"     10",
"    </a>",
"    ]. The American College of Chest Physicians recommends women on low dose aspirin for vascular indications not discontinue this medication because of breastfeeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3803071\">",
"    <span class=\"h3\">",
"     Oral direct thrombin inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"     Dabigatran",
"    </a>",
"    was approved by the FDA in October 2010. While there are no controlled trials of dabigatran in breastfeeding, its pharmacokinetic profile (low molecular weight and low protein binding) suggest that it will pass into breast milk. An alternative anticoagulant should be recommended for breastfeeding mothers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H396541238\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"     Fondaparinux",
"    </a>",
"    is administered subcutaneously; intestinal absorption by the child is unlikely even if the drug enters breast milk; however, the American College of Chest Physicians recommends use of an alternative anticoagulant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/61\">",
"     61",
"    </a>",
"    ]. They also recommend against use of oral direct thrombin (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"     dabigatran",
"    </a>",
"    ) or factor Xa inhibitors (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"     rivaroxaban",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/62/39911?source=see_link\">",
"     apixaban",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    By comparison, they do not consider use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/18/41254?source=see_link\">",
"     danaparoid",
"    </a>",
"    or r-hirudin a contraindication to breastfeeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Phenindione is secreted into breast milk and has been associated with adverse effects in infants when used during breastfeeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. Although data are limited, the American Academy of Pediatrics classified phenindione among drugs that have the potential for significant effects on some nursing infants and should be given to nursing mothers with caution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"     Rivaroxaban",
"    </a>",
"    was approved by the FDA in July 2011. To date, there have been no controlled trials on the use of rivaroxaban in breastfeeding women. Alternatives to consider include injectable low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    products, heparin or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Anticonvulsants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several anticonvulsant medications are listed by the AAP as generally compatible with breastfeeding; however, some are concentrated in milk, with reports of relative infant doses as high as 100 percent.",
"   </p>",
"   <p>",
"    Management of pregnant and nursing women taking anticonvulsants is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/16/15625?source=see_link&amp;anchor=H15#H15\">",
"     \"Management of epilepsy and pregnancy\", section on 'Breast feeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Antihypertensives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antihypertensives are frequently administered in the peripartum period. Within each class of antihypertensive agents, physicians should select the medication with the lowest transfer into human milk. The use of antihypertensive drugs in breastfeeding women is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13434?source=see_link&amp;anchor=H53705226#H53705226\">",
"     \"Management of hypertension in pregnant and postpartum women\", section on 'Options for breastfeeding mothers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Cough and cold products",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of over-the-counter cough and cold products during lactation is a concern due to the widespread use of these medications. Antihistamines and nasal decongestants are among the most commonly used cold medications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Antihistamines",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/39/7799?source=see_link\">",
"     Loratadine",
"    </a>",
"    is the preferred antihistamine in lactation. A study evaluating the excretion of 40 mg of loratadine (four times the average daily dose) in six healthy volunteers indicated that only 0.01 percent of the dose was excreted into milk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of first generation antihistamines, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/52/24390?source=see_link\">",
"     chlorpheniramine",
"    </a>",
"    , are not considered to be associated with any significant adverse reactions in lactation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/8\">",
"     8",
"    </a>",
"    ]. Diphenhydramine enters breast milk.",
"   </p>",
"   <p>",
"    An adverse event has been reported with the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/62/7142?source=see_link\">",
"     clemastine",
"    </a>",
"    , another first-generation antihistamine, in a 10 week old infant. Twelve hours after mother began taking clemastine, the infant was reported to display signs of irritability, drowsiness, resistance to feeding and stiff neck [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/65\">",
"     65",
"    </a>",
"    ]. One day after withdrawal of the medication, the infant's behavior returned to normal. The AAP lists clemastine as a drug associated with significant side effects that should be used with caution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Nasal decongestants",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19190?source=see_link\">",
"     Pseudoephedrine",
"    </a>",
"    is one of the most commonly used nasal decongestants. A study of three patients found 0.4 to 0.6 percent of a single 60 mg dose of pseudoephedrine was transferred into milk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/66\">",
"     66",
"    </a>",
"    ]. The AAP lists pseudoephedrine as compatible with breastfeeding.",
"   </p>",
"   <p>",
"    However,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19190?source=see_link\">",
"     pseudoephedrine",
"    </a>",
"    can decrease milk supply [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. A study of eight women receiving a single 60 mg dose of pseudoephedrine reported 24 hour milk production was reduced by 24 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/68\">",
"     68",
"    </a>",
"    ]. The usual daily dose of pseudoephedrine is 60 mg four times a day. Based on these data, it appears that maternal use of pseudoephedrine could substantially decrease milk supply; therefore, chronic use of pseudoephedrine is not recommended and even acute use should be coupled with close attention to milk supply.",
"   </p>",
"   <p>",
"    Additional options in women with allergic rhinitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37834?source=see_link&amp;anchor=H27574600#H27574600\">",
"     \"Pharmacotherapy of allergic rhinitis\", section on 'Breastfeeding women'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/8/24713?source=see_link&amp;anchor=H10#H10\">",
"     \"Postpartum and postabortion contraception\", section on 'Contraceptive choices during lactation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Analgesics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most analgesics are safe for breastfeeding women.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      enters breast milk, but is considered compatible with breastfeeding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/38/15978?source=see_link\">",
"       Ibuprofen",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/29/38352?source=see_link\">",
"       diclofenac",
"      </a>",
"      suppositories have relative infant doses of less than 1 percent, and are considered compatible with breastfeeding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/69\">",
"       69",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/62/35808?source=see_link\">",
"       Ketorolac",
"      </a>",
"      taken orally also results in very low infant doses and is likely to be safe; however, milk levels have not been measured after higher injectable dosages. In the United States, the FDA requires a \"black box\" warning against breastfeeding during maternal ketorolac use of the injection or tablets.",
"      <br/>",
"      <br/>",
"      Longer acting NSAIDs (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/43/43705?source=see_link\">",
"       naproxen",
"      </a>",
"      ) are best limited to short-term therapy since medications with long half-lives have greater potential to accumulate in the infant's plasma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       Aspirin",
"      </a>",
"      should be used with caution because of the theoretical risk of Reye syndrome. There is a case report of metabolic acidosis in an infant whose mother was taking a high dose of aspirin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Opioid analgesia postpartum may affect infant alertness and suckling vigor; however, adequate treatment of maternal pain is a more important factor for improving breastfeeding outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/69\">",
"     69",
"    </a>",
"    ]. Opiates are generally safe, although infants should be observed for sedation.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"     Meperidine",
"    </a>",
"    is not recommended for nursing women because of consistent reports of dose related neonatal sedation. Its metabolites have a long half-life and may accumulate. A prospective study evaluated the breastfed infants of 102 women undergoing cesarean delivery who were randomly assigned to receive either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    or meperidine patient-controlled analgesia (PCA) postpartum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. Infants whose mothers received meperidine had significantly lower scores on the Brazelton Neonatal Behavioral Assessment Scale. Morphine or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    is preferable to meperidine or pethidine for postpartum analgesia during lactation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/69\">",
"     69",
"    </a>",
"    ]. Morphine has limited transport into milk and poor oral bioavailability in infants. Levels of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9543?source=see_link\">",
"     butorphanol",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/45/14038?source=see_link\">",
"     nalbuphine",
"    </a>",
"    are very low in milk and thus are not likely to affect nursing infants. The weight-adjusted relative infant dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"     hydromorphone",
"    </a>",
"    is 0.67 percent, so hydromorphone is unlikely to reach the infant in clinically significant levels. However, high doses of this drug should be used cautiously and the infant monitored for sedation since the drug is a strong opioid.",
"    <br/>",
"    <br/>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/0/35848?source=see_link\">",
"     Codeine",
"    </a>",
"    is metabolized to morphine by the CYP2D6 enzyme, and ultra-rapid metabolizers have been found to have higher levels of morphine in milk. The prevalence of the CYP2D6 ultra-rapid polymorphism ranges from 1 to 29 percent. A case report described a term infant who died on day of life 13 from apparent narcotic overdose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/16\">",
"     16",
"    </a>",
"    ]. The mother, who was prescribed codeine for management of episiotomy pain, was found to be an ultra-rapid codeine metabolizer.",
"    <br/>",
"    <br/>",
"    Codeine use should be avoided in breastfeeding mothers if an alternative analgesic is available, and women who require codeine should be counseled to monitor their infants for symptoms of narcotic overdose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/73\">",
"     73",
"    </a>",
"    ]. The FDA suggests that when prescribing codeine-containing drugs to nursing mothers, physicians choose the lowest effective dose for the shortest period of time and closely monitor mother-infant pairs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A small amount of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/34/10792?source=see_link\">",
"     oxycodone",
"    </a>",
"    transfers into human milk; prolonged and frequent administration may lead to neonatal sedation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/69\">",
"     69",
"    </a>",
"    ]. Nursing infants of women who carry the CYP2D6 ultra-rapid polymorphism are at higher risk for central nervous system depression.",
"   </p>",
"   <p>",
"    The American Society for Gastrointestinal Endoscopy has provided guidelines for endoscopy in lactating women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/75\">",
"     75",
"    </a>",
"    ]. These guidelines discuss the safety of sedatives and analgesics during the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breastfeeding women who are scheduled to undergo surgery should breastfeed immediately before surgery to minimize the length of infant fast and maternal dehydration. The AAP lists",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    as a drug that may be of concern, citing its high",
"    <span class=\"nowrap\">",
"     milk/plasma",
"    </span>",
"    ratio and its central nervous system effects as a dopaminergic blocking agent; however, there have been no reported adverse effects in exposed infants. This agent is often used preoperatively to promote gastric emptying. A single maternal dose given preoperatively for prevention of gastric aspiration is unlikely to be harmful since metoclopramide is commonly used off-label to increase milk production in lactating women and has also been given therapeutically for reflux in premature neonates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A breastfeeding mother can generally nurse immediately after surgery, with the following guidelines:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mother should be awake and alert",
"     </li>",
"     <li>",
"      The anesthesiologist should be aware that mother is nursing",
"     </li>",
"     <li>",
"      Short-acting benzodiazepines,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/34/15908?source=see_link\">",
"       etomidate",
"      </a>",
"      , muscle relaxants, inhalation agents and local anesthetics can be given and are probably safe [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/69\">",
"       69",
"      </a>",
"      ], but",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"       meperidine",
"      </a>",
"      or prolonged use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      should be avoided. There is no information on use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"       ketamine",
"      </a>",
"      in breastfeeding mothers.",
"     </li>",
"     <li>",
"      Adequate intravenous fluids should be provided to support milk production",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Intravenous contrast agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since most iodinated intravenous contrast agents are highly protein bound and rapidly cleared from maternal circulation, they are present only at very low levels in milk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/77-79\">",
"     77-79",
"    </a>",
"    ]. Moreover, contrast agents have low oral bioavailability, so the infant absorbs a minimal amount of iodine. In a study of 10 newborns who received intravenous contrast media for urographic studies, thyroid function tests were checked at the time of the study and 10 and 30 days later [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/80\">",
"     80",
"    </a>",
"    ]. No abnormalities were found, suggesting that even therapeutic doses of contrast media administered directly to infants do not affect infant thyroid function. Similarly, gadolinium-based contrast agents are present at very low levels in human milk, and no adverse effects have been reported in infants exposed through lactation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/81-83\">",
"     81-83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In their statement on administration of contrast medium to breastfeeding mothers, the American College of Radiology (ACR) estimates that less than 0.01 percent of the maternal dose of iodinated contrast, and less than 0.0004 percent of gadolinium-based contrast, is absorbed by the breastfeeding infant. The ACR concluded that it is safe for women to breastfeed after receiving contrast media, but mothers should be informed of the theoretical risks of direct toxicity or allergic reaction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/84\">",
"     84",
"    </a>",
"    ]. In a review of the literature, the Contrast Media Safety Committee of the European Society of Urogenital Radiology concluded that the amount of gadolinium or iodinated contrast media transferred into milk was insufficient to warrant interruption of breastfeeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/85\">",
"     85",
"    </a>",
"    ]. Women who are concerned about theoretical adverse effects may express and discard milk for 24 hours after the imaging study, which is also the position taken by most manufacturers in their package inserts. Other agents with a long elimination half-life (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/49/29461?source=see_link\">",
"     gadofosveset",
"    </a>",
"    ) may be excreted into milk; therefore, these are not the contrast agents of choice among breastfeeding mothers, and if they are clinically indicated, mothers may wish to consider expressing and discarding milk for 24 hours after the imaging study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Radiopharmaceuticals",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiopharmaceuticals require temporary cessation of breastfeeding. The agent with the shortest half-life should be used. Before receiving the agent, the mother should express milk and store it in a freezer for later use. After the study, she should continue to express milk to maintain production and prevent engorgement, but discard the milk until the radioactive compound has been cleared. Published guidelines are available from the United States Nuclear Regulatory Commission (",
"    <a class=\"graphic graphic_table graphicRef71325 graphicRef82177 \" href=\"mobipreview.htm?40/31/41470\">",
"     table 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/86\">",
"     86",
"    </a>",
"    ]. Radiology departments can also screen milk samples for residual radioactivity before the mother resumes nursing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Social substances",
"    </span>",
"    &nbsp;&mdash;&nbsp;Social substances are transferred into milk at varying levels, and large doses may affect infants.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aspartame is an",
"      <strong>",
"       artificial sweetener",
"      </strong>",
"      . It should be avoided in women or infants with phenylketonuria. Otherwise, it is compatible with breastfeeding.",
"     </li>",
"     <li>",
"      <strong>",
"       Caffeine",
"      </strong>",
"      enters milk, and may accumulate in neonates due to their immature metabolisms. Peak caffeine levels in milk occur 60 to 120 minutes after maternal ingestion. A crossover study of 11 mother-infant pairs in which mothers consumed five cups per day of either decaffeinated coffee or coffee with 100 mg of caffeine per cup found no difference in infant heart rate or sleep patterns during the two exposure periods [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/87\">",
"       87",
"      </a>",
"      ]. Thus, moderate intake of caffeinated beverages does not appear to affect infants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/88\">",
"       88",
"      </a>",
"      ]. The AAP recommends that lactating women consume no more than 200 to 300 mg of caffeine per day (",
"      <a class=\"graphic graphic_table graphicRef79304 \" href=\"mobipreview.htm?30/43/31422\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/35/20026?source=see_link&amp;anchor=H25#H25\">",
"       \"The effects of caffeine on reproductive outcomes in women\", section on 'Lactation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Alcohol",
"      </strong>",
"      is associated with reduced milk production [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/89,90\">",
"       89,90",
"      </a>",
"      ]. It also enters milk, but after about two hours, a single drink (12 oz of beer, 5 oz of wine or 1.5 oz 80-proof liquor) will be cleared completely from the maternal circulation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/89\">",
"       89",
"      </a>",
"      ]. Because alcohol also moves freely from the milk to plasma compartment, it is not necessary to express and discard milk after alcohol has cleared from the mother's circulation. Thus, mothers can be advised to refrain from nursing during alcohol ingestion and for two hours after a single serving of alcohol, but they should wait an additional two hours for each additional serving [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/5,89\">",
"       5,89",
"      </a>",
"      ]. Breastfeeding women should probably avoid imbibing more than one serving of alcohol per day, given these time constraints and risks of excess alcohol consumption. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/61/38874?source=see_link&amp;anchor=H3#H3\">",
"       \"Overview of the risks and benefits of alcohol consumption\", section on 'Definitions and the \"ideal dose\" of alcohol'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Tobacco",
"      </strong>",
"      use is not necessarily a contraindication to breastfeeding, although it should be discouraged because of its overall health risks. Cigarette smoking is associated with decreased milk volume production, lower milk fat concentration, and consequently, shorter duration of lactation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/91-95\">",
"       91-95",
"      </a>",
"      ]. In a cohort study in Adelaide, Australia, of children whose mothers smoked, those who were breastfed had fewer respiratory illnesses than those who were not breastfed, suggesting that the immunologic benefits of breastfeeding mitigated some of the effects of maternal smoking [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/96\">",
"       96",
"      </a>",
"      ]. In another study, breastfed infants of smoking mothers slept less when fed after their mothers smoked recently than when they had abstained [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/97\">",
"       97",
"      </a>",
"      ]. They have urinary cotinine levels up to 10-fold higher than bottle-fed infants of smoking mothers, and up to 50 times higher than infants of nonsmoking mothers [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/98\">",
"       98",
"      </a>",
"      ]. The AAP recommends that pregnancy and lactation be used as opportunities for encouraging smoking cessation. A study of 15 breastfeeding mothers who transitioned from smoking to a nicotine patch found lower levels of nicotine and cotinine in milk as the patch dose was tapered from 21 to 14 to 7 mg [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/99\">",
"       99",
"      </a>",
"      ]. However, use of nicotine replacement products in lactation is controversial. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/53/27482?source=see_link&amp;anchor=H7469948#H7469948\">",
"       \"Smoking and pregnancy\", section on 'Breastfeeding'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Drugs that may be abused",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Drugs of abuse (amphetamines, cocaine, heroin, marijuana, phencyclidine) should not be ingested because they are potentially hazardous to both mother and child.",
"     </li>",
"     <li>",
"      The AAP does not include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/44/32454?source=see_link\">",
"       dextroamphetamine",
"      </a>",
"      in its list of therapeutic agents; amphetamines are listed only as potential drugs of abuse. However, dextroamphetamine may be prescribed therapeutically for attention deficit hyperactivity disorder or narcolepsy. The drug is transferred into milk, at generally low levels (relative infant dose 6 to 14 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/100\">",
"       100",
"      </a>",
"      ]. Adverse effects on nursing infants, such as insomnia, stimulation, or neurodevelopmental abnormalities, have not been reported, but data are sparse [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/100-102\">",
"       100-102",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The AAP lists",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      as compatible with breastfeeding. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/29/4570?source=see_link&amp;anchor=H26#H26\">",
"       \"Methadone maintenance therapy during pregnancy\", section on 'Breastfeeding'",
"      </a>",
"      .).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Silicone breast implants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Silicone breast implants were largely removed from the United States market in 1992 because of concerns over local leakage; however, they were reapproved in 2006. While placement of these devices behind the breast to augment breast tissue usually does not interfere with ability to breastfeed, anecdotal reports suggest that some women who had implants placed through a periareolar incision may experience related difficulties with milk transfer and, ultimately, reduced milk production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Committee on Drugs of the AAP states that the currently available information does not justify classifying silicone implants as a contraindication to breastfeeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/38\">",
"     38",
"    </a>",
"    ]; however, the paucity of safety data has raised some concerns. The only published data on silicon levels in women with implants reported that lactating women with implants had levels of silicon in blood and breast milk that were similar to those in control women. These data also included findings of silicon levels 10 times higher in cow's milk than in human milk, and thousands of times higher in 26 different brands of infant formulas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the evidence that silicone is directly toxic to human tissues is lacking, the possibility has been raised that toxicity may be mediated through an immunologic mechanism. One small series of selected cases noted esophageal dysmotility, although without evidence of associated autoantibodies, in children who were breastfed by mothers with silicone implants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/105\">",
"     105",
"    </a>",
"    ]. Further studies are needed in this area.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Anti-hyperglycemic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Insulin does not enter milk and is compatible with breastfeeding. Three small studies have reported that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    is detectable in milk, but no adverse effects on the infant have been observed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/106-108\">",
"     106-108",
"    </a>",
"    ]. The AAP considers",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/49/42774?source=see_link\">",
"     tolbutamide",
"    </a>",
"    usually compatible with breastfeeding.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/0/6151?source=see_link\">",
"     Chlorpropamide",
"    </a>",
"    enters milk, but is unlikely to cause hypoglycemia; nevertheless, the infant should be observed for signs of low glucose levels if the mother is taking this drug. One study reported neither",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/6/29800?source=see_link\">",
"     glyburide",
"    </a>",
"    nor",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/28/40391?source=see_link\">",
"     glipizide",
"    </a>",
"    was detected in milk of lactating women taking these drugs, but only a few women were evaluated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/1/32794/abstract/109\">",
"     109",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/29/2519?source=see_link&amp;anchor=H17#H17\">",
"     \"Intrapartum and postpartum management of insulin and blood glucose\", section on 'Breastfeeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Immunosuppressive drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/59/38842?source=see_link\">",
"     \"Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1672726604\">",
"    <span class=\"h2\">",
"     Cancer chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breastfeeding is usually not recommended during maternal cancer chemotherapy because these drugs have known maternal toxicities and enter breast milk. There are no data on the risk of morbidity in breastfed infants for most of these drugs, and minimal animal data which may not accurately reflect human breast drug levels and morbidity in human infants. Recommendations about resumption of breastfeeding after chemotherapy vary according to the specific drug. As an example, the manufacturer recommends that women not breastfeed while receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/39/6776?source=see_link\">",
"     trastuzumab",
"    </a>",
"    and for six months following the last dose (because of the long half-life), although there are no data on human breast milk levels or effects on breastfed infants.",
"   </p>",
"   <p>",
"    Manufacturer recommendations may not include data accrued after the FDA&rsquo;s initial approval of the drug and its package labeling. For drugs that are not reviewed in the LactMed database, clinicians can contact other resources for current information on use of specific medications during breastfeeding (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Other resources'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/13/7379?source=see_link\">",
"       \"Patient information: Health and nutrition for women who breastfeed (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/54/31588?source=see_link\">",
"       \"Patient information: Maternal health and nutrition during breastfeeding (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Decisions regarding medication use during lactation require a discussion of the risks of medication exposure versus the risks of not breastfeeding. Drug monographs such as those available through the National Library of Medicine's LactMed web site are a helpful resource for these conversations. Collaboration between care providers for the mother and the infant can greatly facilitate these decisions. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Resources'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Factors that affect the transfer of medications into human milk include timing of the dose with respect to breastfeeding, bioavailability, and maternal clearance. Drugs that are most likely to be transferred from maternal plasma to milk are nonionized, nonprotein bound, of low molecular weight, highly lipid soluble,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      have a high pH. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pharmacodynamics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The LactMed database, produced by the National Library of Medicine, provides monographs on many prescription and over-the-counter medications. The database is available free of charge through the internet (",
"      <a class=\"external\" href=\"file://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT\">",
"       file://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT",
"      </a>",
"      ) and as an iPhone app. (See",
"      <a class=\"local\" href=\"#H396539577\">",
"       'LactMed'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Telephone hotlines are also available for current information and consultation. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Other resources'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When possible, use medications for which data are available regarding safety in infants",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pharmacodynamics in breastfeeding. Use all medications with caution in premature infants. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'General guidelines'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/1\">",
"      Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012; 129:e827.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Global Strategy for Infant and Young Child Feeding. World Health Organization, Geneva 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/3\">",
"      Lee A, Moretti ME, Collantes A, et al. Choice of breastfeeding and physicians' advice: a cohort study of women receiving propylthiouracil. Pediatrics 2000; 106:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/4\">",
"      Ito S, Moretti M, Liau M, Koren G. Initiation and duration of breast-feeding in women receiving antiepileptics. Am J Obstet Gynecol 1995; 172:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/5\">",
"      Akus M, Bartick M. Lactation safety recommendations and reliability compared in 10 medication resources. Ann Pharmacother 2007; 41:1352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/6\">",
"      Ito S, Koren G, Einarson TR. Maternal noncompliance with antibiotics during breastfeeding. Ann Pharmacother 1993; 27:40.",
"     </a>",
"    </li>",
"    <li>",
"     Hale, TW, Ilett, KF. Drug therapy and breastfeeding: from theory to clinical practice, The Parthenon Publishing Group, New York 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/8\">",
"      Ito S. Drug therapy for breast-feeding women. N Engl J Med 2000; 343:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/9\">",
"      Jonker JW, Merino G, Musters S, et al. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat Med 2005; 11:127.",
"     </a>",
"    </li>",
"    <li>",
"     Hale, TW. Medications and mothers' Milk, 10th ed, Pharmasoft Publishing, Amarillo, TX 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/11\">",
"      Ito S, Koren G. A novel index for expressing exposure of the infant to drugs in breast milk. Br J Clin Pharmacol 1994; 38:99.",
"     </a>",
"    </li>",
"    <li>",
"     Hale TW. Caffeine. In: Medications and Mothers' Milk, 10th ed, Pharmasoft Publishing, Amarillo, TX 2002. p.100.",
"    </li>",
"    <li>",
"     Begg, EJ. Clinical Pharmacology Essentials: The Principles Behind the Prescribing Process, Adis International, Auckland 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/14\">",
"      Rodier PM. Developing brain as a target of toxicity. Environ Health Perspect 1995; 103 Suppl 6:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/15\">",
"      Anderson PO, Pochop SL, Manoguerra AS. Adverse drug reactions in breastfed infants: less than imagined. Clin Pediatr (Phila) 2003; 42:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/16\">",
"      Kirchheiner J, Schmidt H, Tzvetkov M, et al. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J 2007; 7:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/17\">",
"      Budd SC, Erdman SH, Long DM, et al. Improved lactation with metoclopramide. A case report. Clin Pediatr (Phila) 1993; 32:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/18\">",
"      Ehrenkranz RA, Ackerman BA. Metoclopramide effect on faltering milk production by mothers of premature infants. Pediatrics 1986; 78:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/19\">",
"      Ertl T, Sulyok E, Ezer E, et al. The influence of metoclopramide on the composition of human breast milk. Acta Paediatr Hung 1991; 31:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/20\">",
"      Gupta AP, Gupta PK. Metoclopramide as a lactogogue. Clin Pediatr (Phila) 1985; 24:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/21\">",
"      Kauppila A, Kivinen S, Ylikorkala O. A dose response relation between improved lactation and metoclopramide. Lancet 1981; 1:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/22\">",
"      Kauppila A, Arvela P, Koivisto M, et al. Metoclopramide and breast feeding: transfer into milk and the newborn. Eur J Clin Pharmacol 1983; 25:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/23\">",
"      Lewis PJ, Devenish C, Kahn C. Controlled trial of metoclopramide in the initiation of breast feeding. Br J Clin Pharmacol 1980; 9:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/24\">",
"      Hansen WF, McAndrew S, Harris K, Zimmerman MB. Metoclopramide effect on breastfeeding the preterm infant: a randomized trial. Obstet Gynecol 2005; 105:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/25\">",
"      da Silva OP, Knoppert DC, Angelini MM, Forret PA. Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial. CMAJ 2001; 164:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/26\">",
"      Johannes CB, Varas-Lorenzo C, McQuay LJ, et al. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study. Pharmacoepidemiol Drug Saf 2010; 19:881.",
"     </a>",
"    </li>",
"    <li>",
"     Swafford, S, Berens, P. Effect of fenugreek on breast milk volume, 5th International Meeting of the Academy of Breastfeeding Medicine, Tucson, AZ 2000.",
"    </li>",
"    <li>",
"     Co, MM, Hernandez, EA, Co, BG. A comparative study on the efficacy of the different galactogogues among mothers with lactational insufficiency, AAP Section on Breastfeeding, NCE, 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/29\">",
"      Zuppa AA, Sindico P, Orchi C, et al. Safety and efficacy of galactogogues: substances that induce, maintain and increase breast milk production. J Pharm Pharm Sci 2010; 13:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/30\">",
"      Damanik R, Wahlqvist ML, Wattanapenpaiboon N. Lactagogue effects of Torbangun, a Bataknese traditional cuisine. Asia Pac J Clin Nutr 2006; 15:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/31\">",
"      Webster J. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Saf 1996; 14:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/32\">",
"      Ferrari C, Piscitelli G, Crosignani PG. Cabergoline: a new drug for the treatment of hyperprolactinaemia. Hum Reprod 1995; 10:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/33\">",
"      Rains CP, Bryson HM, Fitton A. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation. Drugs 1995; 49:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/34\">",
"      Oladapo OT, Fawole B. Treatments for suppression of lactation. Cochrane Database Syst Rev 2012; 9:CD005937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/35\">",
"      de Jong-van den Berg L, Mintzes B. Bromocriptine and lactation suppression: are the risks acceptable? Pharm World Sci 1995; 17:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/36\">",
"      Truitt ST, Fraser AB, Grimes DA, et al. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation. Cochrane Database Syst Rev 2003; :CD003988.",
"     </a>",
"    </li>",
"    <li>",
"     file://toxnet.nlm.nih.gov/cgi-bin/sis/search. (Accessed May 7, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/38\">",
"      American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108:776.",
"     </a>",
"    </li>",
"    <li>",
"     Lawrence, RA, Lawrence, RM. Breastfeeding: A Guide for the Medical Profession, 6th ed, Mosby, Inc, St. Louis 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/40\">",
"      Tunnessen WW Jr, Hertz CG. Toxic effects of lithium in newborn infants: a commentary. J Pediatr 1972; 81:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/41\">",
"      Llewellyn A, Stowe ZN, Strader JR Jr. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 1998; 59 Suppl 6:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/42\">",
"      Moretti ME, Koren G, Verjee Z, Ito S. Monitoring lithium in breast milk: an individualized approach for breast-feeding mothers. Ther Drug Monit 2003; 25:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/43\">",
"      Sykes PA, Quarrie J, Alexander FW. Lithium carbonate and breast-feeding. Br Med J 1976; 2:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/44\">",
"      Havelka J, Hejzlar M, Popov V, et al. Excretion of chloramphenicol in human milk. Chemotherapy 1968; 13:204.",
"     </a>",
"    </li>",
"    <li>",
"     Hale TW, Baker TE. Use of methylergonovine in breastfeeding mothers. file://www.infantrisk.com/content/use-methylergonovine-breastfeeding-mothers-0 (Accessed on August 16, 2012).",
"    </li>",
"    <li>",
"     LactMed file://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT (Accessed on April 23, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/47\">",
"      Burkhardt JE, Walterspiel JN, Schaad UB. Quinolone arthropathy in animals versus children. Clin Infect Dis 1997; 25:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/48\">",
"      Ingham, B, Brentnall, DW, Dale, EA, McFadzean, JA. Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acids. Toxicology Letters 1977; 1:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/49\">",
"      Einarson A, Ho E, Koren G. Can we use metronidazole during pregnancy and breastfeeding? Putting an end to the controversy. Can Fam Physician 2000; 46:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/50\">",
"      Passmore CM, McElnay JC, Rainey EA, D'Arcy PF. Metronidazole excretion in human milk and its effect on the suckling neonate. Br J Clin Pharmacol 1988; 26:45.",
"     </a>",
"    </li>",
"    <li>",
"     Lactmed. Available at file://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~R2NQWq:2. (Accessed on January 19, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/52\">",
"      Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/53\">",
"      Elliott GT, Quinn SL. Sulfisoxazole in human milk. J Pediatr 1981; 99:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/54\">",
"      Kauffman RE, O'Brien C, Gilford P. Sulfisoxazole secretion into human milk. J Pediatr 1980; 97:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/55\">",
"      Forna F, McConnell M, Kitabire FN, et al. Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings. AIDS Rev 2006; 8:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/56\">",
"      Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancy-related mortality surveillance--United States, 1991--1999. MMWR Surveill Summ 2003; 52:1.",
"     </a>",
"    </li>",
"    <li>",
"     Majerus, P, Tollefsen, D. Anticoagulant, thrombolytic and antiplatelet drugs. In: The Pharmacological Basis of Therapeutics, 10th ed, Gilman, A, Hardman, J, Limbird, L (Eds), McGraw-Hill, New York 2001. p. 1519.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/58\">",
"      Clark SL, Porter TF, West FG. Coumarin derivatives and breast-feeding. Obstet Gynecol 2000; 95:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/59\">",
"      Richter C, Sitzmann J, Lang P, et al. Excretion of low molecular weight heparin in human milk. Br J Clin Pharmacol 2001; 52:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/60\">",
"      Guillonneau M, de Crepy A, Aufrant C, et al. [Breast-feeding is possible in case of maternal treatment with enoxaparin]. Arch Pediatr 1996; 3:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/61\">",
"      Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e691S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/62\">",
"      Olthof E, de Vries TW. [Breast feeding and oral anticoagulants]. Tijdschr Kindergeneeskd 1993; 61:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/63\">",
"      Eckstein HB, Jack B. Breast-feeding and anticoagulant therapy. Lancet 1970; 1:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/64\">",
"      Hilbert J, Radwanski E, Affrime MB, et al. Excretion of loratadine in human breast milk. J Clin Pharmacol 1988; 28:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/65\">",
"      Kok TH, Taitz LS, Bennett MJ, Holt DW. Drowsiness due to clemastine transmitted in breast milk. Lancet 1982; 1:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/66\">",
"      Findlay JW, Butz RF, Sailstad JM, et al. Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers. Br J Clin Pharmacol 1984; 18:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/67\">",
"      Hale T, Ilett K, Hartmann P, et al. Pseudoephedrine effects on milk production in women and estimation of infant exposure via human milk. Adv Exp Med Biol 2004; 554:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/68\">",
"      Aljazaf K, Hale TW, Ilett KF, et al. Pseudoephedrine: effects on milk production in women and estimation of infant exposure via breastmilk. Br J Clin Pharmacol 2003; 56:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/69\">",
"      Montgomery A, Hale TW, Academy Of Breastfeeding Medicine. ABM clinical protocol #15: analgesia and anesthesia for the breastfeeding mother, revised 2012. Breastfeed Med 2012; 7:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/70\">",
"      Clark JH, Wilson WG. A 16-day-old breast-fed infant with metabolic acidosis caused by salicylate. Clin Pediatr (Phila) 1981; 20:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/71\">",
"      Wittels B, Scott DT, Sinatra RS. Exogenous opioids in human breast milk and acute neonatal neurobehavior: a preliminary study. Anesthesiology 1990; 73:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/72\">",
"      Wittels B, Glosten B, Faure EA, et al. Postcesarean analgesia with both epidural morphine and intravenous patient-controlled analgesia: neurobehavioral outcomes among nursing neonates. Anesth Analg 1997; 85:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/73\">",
"      Koren G, Cairns J, Chitayat D, et al. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 2006; 368:704.",
"     </a>",
"    </li>",
"    <li>",
"     www.fda.gov/medwatch/safety/2007/safety07.htm#Codeine.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/75\">",
"      ASGE Standard of Practice Committee, Shergill AK, Ben-Menachem T, et al. Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc 2012; 76:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/76\">",
"      Meadow WL, Bui KC, Strates E, Dean R. Metoclopramide promotes enteral feeding in preterm infants with feeding intolerance. Dev Pharmacol Ther 1989; 13:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/77\">",
"      Ilett KF, Hackett LP, Paterson JW, McCormick CC. Excretion of metrizamide in milk. Br J Radiol 1981; 54:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/78\">",
"      FitzJohn TP, Williams DG, Laker MF, Owen JP. Intravenous urography during lactation. Br J Radiol 1982; 55:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/79\">",
"      Nielsen ST, Matheson I, Rasmussen JN, et al. Excretion of iohexol and metrizoate in human breast milk. Acta Radiol 1987; 28:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/80\">",
"      Bona G, Zaffaroni M, Defilippi C, et al. Effects of iopamidol on neonatal thyroid function. Eur J Radiol 1992; 14:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/81\">",
"      Rofsky NM, Weinreb JC, Litt AW. Quantitative analysis of gadopentetate dimeglumine excreted in breast milk. J Magn Reson Imaging 1993; 3:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/82\">",
"      Kubik-Huch RA, Gottstein-Aalame NM, Frenzel T, et al. Gadopentetate dimeglumine excretion into human breast milk during lactation. Radiology 2000; 216:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/83\">",
"      Schmiedl U, Maravilla KR, Gerlach R, Dowling CA. Excretion of gadopentetate dimeglumine in human breast milk. AJR Am J Roentgenol 1990; 154:1305.",
"     </a>",
"    </li>",
"    <li>",
"     ACR Committee on Drugs and Contrast Media. Administration of Contrast Medium to Breastfeeding Mothers. ACR Bulletin 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/85\">",
"      Webb JA, Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005; 15:1234.",
"     </a>",
"    </li>",
"    <li>",
"     US Nuclear Regulatory Commission. Activities of Radiopharmaceuticals that Require Instructions and Records When Administered to Patients Who are Breast-Feeding an Infant or Child. In: Program-Specific Guidance About Medical Use Licenses - Final Report (NUREG-1556, Vol. 9), USGPO, Washington, DC 2002. p. U-8.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/87\">",
"      Ryu JE. Effect of maternal caffeine consumption on heart rate and sleep time of breast-fed infants. Dev Pharmacol Ther 1985; 8:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/88\">",
"      Ryu JE. Caffeine in human milk and in serum of breast-fed infants. Dev Pharmacol Ther 1985; 8:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/89\">",
"      Ho E, Collantes A, Kapur BM, et al. Alcohol and breast feeding: calculation of time to zero level in milk. Biol Neonate 2001; 80:219.",
"     </a>",
"    </li>",
"    <li>",
"     Mennella, JA. Alcohol use during lactation: effects on the mother and the breastfeeding infant. In: Nutrition and Alcohol. Watson, RR, Preedy, VR (Eds), CRC Press, Florida 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/91\">",
"      Horta BL, Kramer MS, Platt RW. Maternal smoking and the risk of early weaning: a meta-analysis. Am J Public Health 2001; 91:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/92\">",
"      Giglia R, Binns CW, Alfonso H. Maternal cigarette smoking and breastfeeding duration. Acta Paediatr 2006; 95:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/93\">",
"      Vio F, Salazar G, Infante C. Smoking during pregnancy and lactation and its effects on breast-milk volume. Am J Clin Nutr 1991; 54:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/94\">",
"      Agostoni C, Marangoni F, Grandi F, et al. Earlier smoking habits are associated with higher serum lipids and lower milk fat and polyunsaturated fatty acid content in the first 6 months of lactation. Eur J Clin Nutr 2003; 57:1466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/95\">",
"      Hill PD, Aldag JC. Smoking and breastfeeding status. Res Nurs Health 1996; 19:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/96\">",
"      Woodward A, Douglas RM, Graham NM, Miles H. Acute respiratory illness in Adelaide children: breast feeding modifies the effect of passive smoking. J Epidemiol Community Health 1990; 44:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/97\">",
"      Mennella JA, Yourshaw LM, Morgan LK. Breastfeeding and smoking: short-term effects on infant feeding and sleep. Pediatrics 2007; 120:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/98\">",
"      Mascola MA, Van Vunakis H, Tager IB, et al. Exposure of young infants to environmental tobacco smoke: breast-feeding among smoking mothers. Am J Public Health 1998; 88:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/99\">",
"      Ilett KF, Hale TW, Page-Sharp M, et al. Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk. Clin Pharmacol Ther 2003; 74:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/100\">",
"      Ilett KF, Hackett LP, Kristensen JH, Kohan R. Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder. Br J Clin Pharmacol 2007; 63:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/101\">",
"      Steiner E, Vill&eacute;n T, Hallberg M, Rane A. Amphetamine secretion in breast milk. Eur J Clin Pharmacol 1984; 27:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/102\">",
"      Ayd, FJ. Excretion of psychotropic drugs in human breast milk. Int Drug Ther News 1973; 8:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/103\">",
"      Strom SS, Baldwin BJ, Sigurdson AJ, Schusterman MA. Cosmetic saline breast implants: a survey of satisfaction, breast-feeding experience, cancer screening, and health. Plast Reconstr Surg 1997; 100:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/104\">",
"      Semple JL, Lugowski SJ, Baines CJ, et al. Breast milk contamination and silicone implants: preliminary results using silicon as a proxy measurement for silicone. Plast Reconstr Surg 1998; 102:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/105\">",
"      Levine JJ, Ilowite NT. Sclerodermalike esophageal disease in children breast-fed by mothers with silicone breast implants. JAMA 1994; 271:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/106\">",
"      Gardiner SJ, Begg EJ, Kirkpatrick CM, Buckham RB. Metformin therapy and diabetes in pregnancy. Med J Aust 2004; 181:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/107\">",
"      Hale TW, Kristensen JH, Hackett LP, et al. Transfer of metformin into human milk. Diabetologia 2002; 45:1509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/108\">",
"      Briggs GG, Ambrose PJ, Nageotte MP, et al. Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol 2005; 105:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/1/32794/abstract/109\">",
"      Feig DS, Briggs GG, Kraemer JM, et al. Transfer of glyburide and glipizide into breast milk. Diabetes Care 2005; 28:1851.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6709 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-190.81.197.98-B6AD16F21F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32794=[""].join("\n");
var outline_f32_1_32794=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARMACODYNAMICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DRUG EFFECTS ON MILK SUPPLY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Increase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Decrease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H396539577\">",
"      LactMed",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H396539584\">",
"      American Academy of Pediatrics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H396539591\">",
"      Books",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33601704\">",
"      UpToDate drug database",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other resources",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      GENERAL GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MEDICATIONS GENERALLY CONTRAINDICATED",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DRUGS BY CATEGORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Antimicrobials",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H396541163\">",
"      - Overview",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H396541138\">",
"      - Ofloxacin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H396541156\">",
"      - Metronidazole and tinidazole",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H408248\">",
"      - Sulfonamides",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Psychotropic medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Antithrombotic agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H396541202\">",
"      - Unfractionated heparin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H396541231\">",
"      - Warfarin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H396541209\">",
"      - Low molecular weight heparins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H396541216\">",
"      - Antiplatelet drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3803071\">",
"      - Oral direct thrombin inhibitor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H396541238\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Anticonvulsants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Antihypertensives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Cough and cold products",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Antihistamines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Nasal decongestants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Contraception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Analgesics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Anesthesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Intravenous contrast agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Radiopharmaceuticals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Social substances",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Drugs that may be abused",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Silicone breast implants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Anti-hyperglycemic agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Immunosuppressive drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1672726604\">",
"      Cancer chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6709\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6709|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/62/36845\" title=\"table 1A\">",
"      Radiopharmaceuticals A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/35/25149\" title=\"table 1B\">",
"      Radiopharmaceuticals B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/43/31422\" title=\"table 2\">",
"      Caffeine content",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/15/17658?source=related_link\">",
"      Common problems of breastfeeding and weaning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/29/2519?source=related_link\">",
"      Intrapartum and postpartum management of insulin and blood glucose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/16/15625?source=related_link\">",
"      Management of epilepsy and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13434?source=related_link\">",
"      Management of hypertension in pregnant and postpartum women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/29/4570?source=related_link\">",
"      Methadone maintenance therapy during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/61/38874?source=related_link\">",
"      Overview of the risks and benefits of alcohol consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/13/7379?source=related_link\">",
"      Patient information: Health and nutrition for women who breastfeed (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/54/31588?source=related_link\">",
"      Patient information: Maternal health and nutrition during breastfeeding (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37834?source=related_link\">",
"      Pharmacotherapy of allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/8/24713?source=related_link\">",
"      Postpartum and postabortion contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/53/27482?source=related_link\">",
"      Smoking and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/35/20026?source=related_link\">",
"      The effects of caffeine on reproductive outcomes in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/59/38842?source=related_link\">",
"      Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38745?source=related_link\">",
"      Use of psychotropic medications in breastfeeding women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_1_32795="HTLV-I genome organization";
var content_f32_1_32795=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F61279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F61279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 506px\">",
"   <div class=\"ttl\">",
"    Organization of the HTLV-I genome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 486px; height: 126px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32795=[""].join("\n");
var outline_f32_1_32795=null;
var title_f32_1_32796="Foods products with gluten";
var content_f32_1_32796=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F79790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F79790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Foods and products that may contain gluten",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tr>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Frequently overlooked foods that may contain gluten and need to be verified:",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Brown rice syrup",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Breading and coating mixes",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Croutons",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Energy bars",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Flour or cereal products",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Imitation bacon",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Imitation seafood",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Marinades",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Panko (Japanese bread crumbs)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Pastas",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Processed luncheon meats",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Sauces, gravies",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Self-basting poultry",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Soy sauce or soy sauce solids",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Soup bases",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Stuffings, dressing",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Thickeners (roux)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Communion wafers",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Herbal supplements",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Drugs and over-the-counter medications",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Nutritional supplements",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Vitamins and mineral supplements",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Play-dough, crayons, paint, glue, paper mache: A potential problem if the child puts their hands on or in the mouth while playing. Wash hands after using these products.",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          NOT ALLOWED in any form:",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Wheat (einkorn, durum, faro, graham, kamut, semolina, spelt)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Rye",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Barley",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Triticale",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Malt, malt flavoring, malt vinegar (are generally made from barley, verify the source)",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission: \"Frequently overlooked foods that may contain gluten and need to be verified.\" From Quick Start Diet Guide for Celiac Disease &copy; 2009. Celiac Disease Foundation. www.celiac.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32796=[""].join("\n");
var outline_f32_1_32796=null;
var title_f32_1_32797="LV diastolic pressure volume relationship";
var content_f32_1_32797=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59748&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59748&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left ventricular diastolic pressure-volume relationship in ischemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 323px; height: 246px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The left ventricular (LV) diastolic pressure as a function of the LV volume defines LV diastolic distensibility or compliance. With exercise and the provocation of ischemia, there is a shift of the pressure- volume curve upward, indicating a reduction in LV compliance. A relatively stiff, noncomplaint ventricle requires higher pressure to achieve filling of a given volume.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Carroll JD, Carroll EP. Herz 1991; 16:1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32797=[""].join("\n");
var outline_f32_1_32797=null;
var title_f32_1_32798="Mild Hunter syndrome A";
var content_f32_1_32798=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64748&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64748&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mild mucopolysaccharidosis type II (MPS II, Hunter syndrome) A",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 151px; height: 366px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mild Hunter syndrome (MPS II) in a 12-year-old boy (frontal view).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ed Wraith, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32798=[""].join("\n");
var outline_f32_1_32798=null;
var title_f32_1_32799="Swan Ganz balloon inflation";
var content_f32_1_32799=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Balloon inflation of pulmonary artery catheter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 264px; height: 384px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This schematic diagram shows the appearance of a pulmonary artery (Swan-Ganz) catheter tip with the balloon at full inflation (top) and at less than full inflation (bottom). The tip of the catheter protrudes beyond the balloon when the balloon is less than fully inflated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_1_32799=[""].join("\n");
var outline_f32_1_32799=null;
